<graphml xmlns="http://graphml.graphdrawing.org/xmlns" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://graphml.graphdrawing.org/xmlns http://graphml.graphdrawing.org/xmlns/1.0/graphml.xsd">
  <key id="d6" for="edge" attr.name="source_id" attr.type="string" />
  <key id="d5" for="edge" attr.name="description" attr.type="string" />
  <key id="d4" for="edge" attr.name="weight" attr.type="double" />
  <key id="d3" for="node" attr.name="entity_type" attr.type="string" />
  <key id="d2" for="node" attr.name="source_id" attr.type="string" />
  <key id="d1" for="node" attr.name="description" attr.type="string" />
  <key id="d0" for="node" attr.name="type" attr.type="string" />
  <graph edgedefault="undirected">
    <node id="TNFSF4">
      <data key="d0">GENE</data>
      <data key="d1">TNFSF4, also known as OX40L, is a gene from the tumour necrosis factor ligand superfamily member 4 that encodes for the T cell costimulatory molecule OX40 ligand. This gene is associated with susceptibility to autoimmune diseases such as systemic lupus erythematosus (SLE) and systemic sclerosis (SSc).</data>
      <data key="d2">31513af83d109f0e11eca33fa5fb3204,5639a5e5649646c1e4c8deb1e1f0a1b1,5db9eda60231516215dcb8b82826f9bc,87174642d9d24116b8cc01fca23746f2,ab372f2a5df06a33e153fa648bb2b950,c89a7a896cf934207d874042e48857da</data>
    </node>
    <node id="OX40L">
      <data key="d0">PROTEIN</data>
      <data key="d1">OX40L, also known as OX40 Ligand, is a protein encoded by the TNFSF4 gene. It functions as a ligand for the OX40 receptor, which is a member of the tumor necrosis factor (TNF) superfamily. OX40L is expressed on the surface of various immune and non-immune cells, including monocytes, and plays a crucial role in immune responses. It provides a costimulatory signal essential for T cell activation, proliferation, survival, and cytokine production. Additionally, OX40L enhances B cell proliferation and is particularly important for the generation of Th2 memory cells. This protein is highly expressed in patients with atopic dermatitis, indicating its involvement in the pathogenesis of this condition. Overall, OX40L is a key player in T cell costimulatory signaling and is critical for effective immune function.</data>
      <data key="d2">05fe283d6fa879523f3ab153815ac64b,2712037f85fc28b3e86b92a719cb7a6c,2f4bf4583547aaf1c5cc6eaea0b058eb,7a1160d4230f62889d47499ed90adcdd,87174642d9d24116b8cc01fca23746f2,919f7083e77a7d3378489efeffa0faed,a98a120ac25d0f8a533fcdcd479913b1,ab372f2a5df06a33e153fa648bb2b950,f286191a8009d9c0ef61d3de0938f0e6</data>
    </node>
    <node id="SLE">
      <data key="d0">DISEASE</data>
      <data key="d1">Systemic lupus erythematosus (SLE) is an autoimmune disease characterized by the immune system attacking its own tissues. It is associated with TNFSF4, a gene that plays a role in the disease's pathogenesis.</data>
      <data key="d2">5639a5e5649646c1e4c8deb1e1f0a1b1,87174642d9d24116b8cc01fca23746f2,ab372f2a5df06a33e153fa648bb2b950,c89a7a896cf934207d874042e48857da</data>
    </node>
    <node id="SSC">
      <data key="d0">DISEASE</data>
      <data key="d1">Systemic sclerosis (SSC), also known as scleroderma, is a chronic, clinically heterogeneous autoimmune disease characterized by progressive fibrosis of the skin and internal organs. This multisystem disease is associated with the TNFSF4 gene and various single nucleotide polymorphisms (SNPs), including rs2205960, rs855648, and rs944648.</data>
      <data key="d2">31513af83d109f0e11eca33fa5fb3204,5639a5e5649646c1e4c8deb1e1f0a1b1,5db9eda60231516215dcb8b82826f9bc,87174642d9d24116b8cc01fca23746f2,ab372f2a5df06a33e153fa648bb2b950,c89a7a896cf934207d874042e48857da,e2d4a3467d27e6de3b2eea8b20f310e8</data>
    </node>
    <node id="RS1234314">
      <data key="d0">SNP</data>
      <data key="d1">Single nucleotide polymorphism rs1234314 in the TNFSF4 gene region is associated with susceptibility to systemic sclerosis.</data>
      <data key="d2">31513af83d109f0e11eca33fa5fb3204,5db9eda60231516215dcb8b82826f9bc,87174642d9d24116b8cc01fca23746f2,c89a7a896cf934207d874042e48857da,e2d4a3467d27e6de3b2eea8b20f310e8</data>
    </node>
    <node id="RS2205960">
      <data key="d0">SNP</data>
      <data key="d1">Single nucleotide polymorphism rs2205960 in the TNFSF4 gene region is associated with susceptibility to systemic sclerosis.</data>
      <data key="d2">31513af83d109f0e11eca33fa5fb3204,5639a5e5649646c1e4c8deb1e1f0a1b1,5db9eda60231516215dcb8b82826f9bc,87174642d9d24116b8cc01fca23746f2,ab372f2a5df06a33e153fa648bb2b950,c89a7a896cf934207d874042e48857da,e2d4a3467d27e6de3b2eea8b20f310e8,f286191a8009d9c0ef61d3de0938f0e6</data>
    </node>
    <node id="RS844648">
      <data key="d0">SNP</data>
      <data key="d1">Single nucleotide polymorphism rs844648 in the TNFSF4 gene region is associated with susceptibility to systemic sclerosis.</data>
      <data key="d2">31513af83d109f0e11eca33fa5fb3204,5db9eda60231516215dcb8b82826f9bc,87174642d9d24116b8cc01fca23746f2,c89a7a896cf934207d874042e48857da,e2d4a3467d27e6de3b2eea8b20f310e8</data>
    </node>
    <node id="RS844644">
      <data key="d0">SNP</data>
      <data key="d1">Single nucleotide polymorphism rs844644 in the TNFSF4 gene region is associated with systemic sclerosis. While some studies suggest that rs844644 may be protective against systemic sclerosis, the majority of the literature indicates a significant association between this polymorphism and the susceptibility to the disease. Therefore, rs844644 in the TNFSF4 gene is an important genetic marker linked to systemic sclerosis.</data>
      <data key="d2">31513af83d109f0e11eca33fa5fb3204,5db9eda60231516215dcb8b82826f9bc,87174642d9d24116b8cc01fca23746f2,c89a7a896cf934207d874042e48857da,e2d4a3467d27e6de3b2eea8b20f310e8</data>
    </node>
    <node id="PTPN22">
      <data key="d0">GENE</data>
      <data key="d1">PTPN22 is a gene associated with the susceptibility to systemic sclerosis (SSc) and the development of multiple autoimmune diseases, including type I diabetes mellitus, rheumatoid arthritis, and systemic lupus erythematosus. It encodes a protein tyrosine phosphatase, which plays a significant role in the pathogenesis of these conditions.</data>
      <data key="d2">5639a5e5649646c1e4c8deb1e1f0a1b1,87174642d9d24116b8cc01fca23746f2,ab372f2a5df06a33e153fa648bb2b950</data>
    </node>
    <node id="TIDM">
      <data key="d0">DISEASE</data>
      <data key="d1">Type I diabetes mellitus, an autoimmune disease where the immune system attacks insulin-producing cells in the pancreas</data>
      <data key="d2">87174642d9d24116b8cc01fca23746f2</data>
    </node>
    <node id="RA">
      <data key="d0">DISEASE</data>
      <data key="d1">Rheumatoid arthritis (RA) is an autoimmune disease characterized by chronic inflammation of the joints. It is a condition that may share genetic risk factors with other autoimmune diseases such as systemic sclerosis (SSc) and systemic lupus erythematosus (SLE).</data>
      <data key="d2">87174642d9d24116b8cc01fca23746f2,ab372f2a5df06a33e153fa648bb2b950</data>
    </node>
    <node id="STAT4">
      <data key="d0">GENE</data>
      <data key="d1">STAT4 is a gene associated with susceptibility to systemic sclerosis (SSc), systemic lupus erythematosus (SLE), and rheumatoid arthritis (RA). It plays a significant role in influencing the genetic predisposition to these autoimmune diseases, highlighting its importance in the pathogenesis and potential therapeutic targeting of SSc, SLE, and RA.</data>
      <data key="d2">5639a5e5649646c1e4c8deb1e1f0a1b1,87174642d9d24116b8cc01fca23746f2,ab372f2a5df06a33e153fa648bb2b950</data>
    </node>
    <node id="IRF5">
      <data key="d0">GENE</data>
      <data key="d1">IRF5 is a gene associated with systemic sclerosis (SSc) susceptibility. It is also linked to polymorphisms that are associated with systemic lupus erythematosus (SLE) and systemic sclerosis. Furthermore, IRF5 has functional variants that define risk and protective haplotypes for human lupus.</data>
      <data key="d2">5639a5e5649646c1e4c8deb1e1f0a1b1,87174642d9d24116b8cc01fca23746f2,ab372f2a5df06a33e153fa648bb2b950</data>
    </node>
    <node id="FAS">
      <data key="d0">GENE</data>
      <data key="d1">FAS is a gene associated with polymorphisms linked to systemic lupus erythematosus and systemic sclerosis. It has a promoter region polymorphism that influences susceptibility to both systemic sclerosis and systemic lupus erythematosus. The gene is notably associated with systemic sclerosis susceptibility, highlighting its significant role in the pathogenesis of these autoimmune diseases.</data>
      <data key="d2">5639a5e5649646c1e4c8deb1e1f0a1b1,87174642d9d24116b8cc01fca23746f2,ab372f2a5df06a33e153fa648bb2b950</data>
    </node>
    <node id="CREST">
      <data key="d0">SYMPTOM</data>
      <data key="d1">CREST stands for Calcinosis, Raynaud&#8217;s phenomenon, Esophageal dysfunction, Sclerodactyly, and Telangiectasias, which are features used in disease classification. CREST syndrome is a subset of systemic sclerosis characterized by these same features: Calcinosis, Raynaud&#8217;s phenomenon, Esophageal dysfunction, Sclerodactyly, and Telangiectasias.</data>
      <data key="d2">87174642d9d24116b8cc01fca23746f2,c89a7a896cf934207d874042e48857da</data>
    </node>
    <node id="CALCINOSIS">
      <data key="d0">SYMPTOM</data>
      <data key="d1">Calcinosis is the formation of calcium deposits in the skin and other tissues. It is a notable feature of CREST syndrome, a subset of systemic sclerosis.</data>
      <data key="d2">87174642d9d24116b8cc01fca23746f2,c89a7a896cf934207d874042e48857da</data>
    </node>
    <node id="RAYNAUD&#8217;S PHENOMENON">
      <data key="d0">SYMPTOM</data>
      <data key="d1">Raynaud&#8217;s phenomenon is a condition characterized by reduced blood flow to the extremities, causing them to turn white or blue. This condition is often triggered by cold or stress and is a feature of CREST syndrome.</data>
      <data key="d2">87174642d9d24116b8cc01fca23746f2,c89a7a896cf934207d874042e48857da</data>
    </node>
    <node id="ESOPHAGEAL DYSFUNCTION">
      <data key="d0">SYMPTOM</data>
      <data key="d1">Esophageal dysfunction refers to problems with the esophagus, such as difficulty swallowing or acid reflux. It is a feature of CREST syndrome, which includes difficulty in swallowing or other esophageal issues.</data>
      <data key="d2">87174642d9d24116b8cc01fca23746f2,c89a7a896cf934207d874042e48857da</data>
    </node>
    <node id="SCLERODACTYLY">
      <data key="d0">SYMPTOM</data>
      <data key="d1">Sclerodactyly is a condition characterized by the thickening and tightening of the skin on the fingers and hands. It is a notable feature of CREST syndrome, which is a subset of systemic sclerosis.</data>
      <data key="d2">87174642d9d24116b8cc01fca23746f2,c89a7a896cf934207d874042e48857da</data>
    </node>
    <node id="TELANGIECTASIAS">
      <data key="d0">SYMPTOM</data>
      <data key="d1">Telangiectasias are small, dilated blood vessels located near the surface of the skin. They are a notable feature of CREST syndrome and are often observed in individuals with systemic sclerosis. These widened blood vessels can be a visible manifestation of underlying autoimmune conditions, highlighting their relevance in the clinical presentation of these diseases.</data>
      <data key="d2">87174642d9d24116b8cc01fca23746f2,c89a7a896cf934207d874042e48857da</data>
    </node>
    <node id="AUTOIMMUNE DISEASES">
      <data key="d0">DISEASE</data>
      <data key="d1">Autoimmune diseases are conditions where the immune system mistakenly attacks the body's own tissues</data>
      <data key="d2">87174642d9d24116b8cc01fca23746f2</data>
    </node>
    <node id="ATHEROSCLEROSIS">
      <data key="d0">DISEASE</data>
      <data key="d1">Atherosclerosis is a disease characterized by the buildup of fats, cholesterol, and other substances in and on the artery walls</data>
      <data key="d2">87174642d9d24116b8cc01fca23746f2</data>
    </node>
    <node id="MYOSITIS">
      <data key="d0">DISEASE</data>
      <data key="d1">Myositis is an inflammation of the muscles that can be a symptom in various autoimmune diseases. It can cause muscle weakness and pain.</data>
      <data key="d2">87174642d9d24116b8cc01fca23746f2,c89a7a896cf934207d874042e48857da</data>
    </node>
    <node id="SJOGREN'S SYNDROME">
      <data key="d0">DISEASE</data>
      <data key="d1">Sjogren's syndrome is an autoimmune disease characterized by dry eyes and dry mouth</data>
      <data key="d2">87174642d9d24116b8cc01fca23746f2,c89a7a896cf934207d874042e48857da</data>
    </node>
    <node id="INTERFERON REGULATORY FACTOR 5">
      <data key="d0">GENE</data>
      <data key="d1">Interferon regulatory factor 5 (IRF5) is a gene associated with polymorphisms linked to systemic lupus erythematosus and systemic sclerosis</data>
      <data key="d2">87174642d9d24116b8cc01fca23746f2</data>
    </node>
    <node id="TYPE I INTERFERON">
      <data key="d0">BIOLOGICALPATHWAY</data>
      <data key="d1">Type I interferon expression, in combination with OX40L, may induce a Th1 response. The Type I interferon pathway is involved in the immune response and is upregulated in patients with systemic lupus erythematosus and systemic sclerosis.</data>
      <data key="d2">87174642d9d24116b8cc01fca23746f2,ab372f2a5df06a33e153fa648bb2b950</data>
    </node>
    <node id="ANTIBODIES">
      <data key="d0">PROTEIN</data>
      <data key="d1">Antinuclear antibodies are a type of antibody that targets the nucleus of cells and are found in patients with autoimmune diseases like SLE and SScAntibodies are proteins produced by the immune system to help fight infections and are found in patients with autoimmune diseases like SLE and SSc</data>
      <data key="d2">87174642d9d24116b8cc01fca23746f2</data>
      <data key="d3">PROTEIN</data>
    </node>
    <node id="EXTRACELLULAR MATRIX">
      <data key="d0">BIOLOGICALPATHWAY</data>
      <data key="d1">Extracellular matrix deposition is a process involved in the pathology of systemic sclerosis, leading to fibrosis</data>
      <data key="d2">87174642d9d24116b8cc01fca23746f2</data>
    </node>
    <node id="INFLAMMATION">
      <data key="d0">BIOLOGICALPATHWAY</data>
      <data key="d1">Inflammation is a biological response to harmful stimuli and is a key feature in autoimmune diseases like SLE and SSc</data>
      <data key="d2">87174642d9d24116b8cc01fca23746f2</data>
    </node>
    <node id="VASCULOPATHY">
      <data key="d0">BIOLOGICALPATHWAY</data>
      <data key="d1">Vasculopathy is a disease of the blood vessels and is one of the cardinal features of systemic sclerosis</data>
      <data key="d2">87174642d9d24116b8cc01fca23746f2</data>
    </node>
    <node id="FIBROSIS">
      <data key="d0">BIOLOGICALPATHWAY</data>
      <data key="d1">Fibrosis is the thickening and scarring of connective tissue, often as a result of injury, and is a hallmark of systemic sclerosis</data>
      <data key="d2">87174642d9d24116b8cc01fca23746f2</data>
    </node>
    <node id="HEP-2 CELLS">
      <data key="d0">CELL_LINE</data>
      <data key="d1">HEp-2 cells are a cell line used as an antigen substrate in immunofluorescence assays</data>
      <data key="d2">c89a7a896cf934207d874042e48857da</data>
    </node>
    <node id="ANTINUCLEAR ANTIBODIES">
      <data key="d0">PROTEIN</data>
      <data key="d1">Antinuclear antibodies are autoantibodies that bind to contents of the cell nucleus</data>
      <data key="d2">c89a7a896cf934207d874042e48857da</data>
    </node>
    <node id="ANTI-CENTROMERE ANTIBODIES">
      <data key="d0">PROTEIN</data>
      <data key="d1">Anti-centromere antibodies are autoantibodies that target the centromere of chromosomes. These autoantibodies are associated with systemic sclerosis, an autoimmune disease characterized by the hardening and tightening of the skin and connective tissues.</data>
      <data key="d2">5639a5e5649646c1e4c8deb1e1f0a1b1,c89a7a896cf934207d874042e48857da</data>
    </node>
    <node id="TOPOISOMERASE I">
      <data key="d0">PROTEIN</data>
      <data key="d1">Topoisomerase I is an enzyme that helps relieve strain in DNA by breaking and rejoining the DNA strand</data>
      <data key="d2">c89a7a896cf934207d874042e48857da</data>
    </node>
    <node id="ANTI-RNA POLYMERASE III ANTIBODIES">
      <data key="d0">PROTEIN</data>
      <data key="d1">Anti-RNA polymerase III antibodies are autoantibodies that target RNA polymerase III</data>
      <data key="d2">c89a7a896cf934207d874042e48857da</data>
    </node>
    <node id="RS1234315">
      <data key="d0">SNP</data>
      <data key="d1">Single nucleotide polymorphism rs1234315 of the TNFSF4 gene is associated with systemic sclerosis</data>
      <data key="d2">c89a7a896cf934207d874042e48857da</data>
    </node>
    <node id="RS12039904">
      <data key="d0">SNP</data>
      <data key="d1">Single nucleotide polymorphism rs12039904 of the TNFSF4 gene is associated with systemic sclerosis</data>
      <data key="d2">c89a7a896cf934207d874042e48857da</data>
    </node>
    <node id="RS2795288">
      <data key="d0">SNP</data>
      <data key="d1">Single nucleotide polymorphism rs2795288 of the TNFSF4 gene is associated with systemic sclerosis</data>
      <data key="d2">c89a7a896cf934207d874042e48857da</data>
    </node>
    <node id="RS844665">
      <data key="d0">SNP</data>
      <data key="d1">RS844665 is a single nucleotide polymorphism (SNP) located in the TNFSF4 gene. The association of rs844665 with systemic sclerosis has been a subject of research, with some studies indicating a significant link, while others do not find a significant association. Despite these conflicting reports, the SNP rs844665 in the TNFSF4 gene remains a point of interest in the study of systemic sclerosis.</data>
      <data key="d2">31513af83d109f0e11eca33fa5fb3204,5db9eda60231516215dcb8b82826f9bc,c89a7a896cf934207d874042e48857da,e2d4a3467d27e6de3b2eea8b20f310e8</data>
    </node>
    <node id="RS10912580">
      <data key="d0">SNP</data>
      <data key="d1">Single nucleotide polymorphism rs10912580 of the TNFSF4 gene is associated with systemic sclerosis</data>
      <data key="d2">c89a7a896cf934207d874042e48857da</data>
    </node>
    <node id="PUREGENE GENOMIC DNA ISOLATION KIT">
      <data key="d0">CHEMICAL</data>
      <data key="d1">PureGene genomic DNA isolation kit is used for extracting genomic DNA from peripheral blood</data>
      <data key="d2">c89a7a896cf934207d874042e48857da</data>
    </node>
    <node id="ABI TAQMAN SNP GENOTYPING ASSAY">
      <data key="d0">CHEMICAL</data>
      <data key="d1">ABI TaqMan SNP genotyping assay is used for genotyping single nucleotide polymorphisms</data>
      <data key="d2">c89a7a896cf934207d874042e48857da</data>
    </node>
    <node id="SAS">
      <data key="d0">CHEMICAL</data>
      <data key="d1">SAS is a software used for statistical analysis</data>
      <data key="d2">c89a7a896cf934207d874042e48857da</data>
    </node>
    <node id="HAPLOVIEW">
      <data key="d0">CHEMICAL</data>
      <data key="d1">Haploview is a software used for analyzing linkage disequilibrium and haplotype maps</data>
      <data key="d2">c89a7a896cf934207d874042e48857da</data>
    </node>
    <node id="CART">
      <data key="d0">CHEMICAL</data>
      <data key="d1">CART, which stands for Classification and Regression Tree analysis, is a statistical method used to explore interactions between variables. Specifically, Cartesian and regression tree analysis (CART) is employed to show interactions between TNFSF4 SNPs in systemic sclerosis (SSc). This method is valuable in understanding the complex relationships and interactions within genetic data related to autoimmune diseases such as systemic sclerosis.</data>
      <data key="d2">ab372f2a5df06a33e153fa648bb2b950,c89a7a896cf934207d874042e48857da</data>
    </node>
    <node id="ANTI-TOPOISOMERASE I ANTIBODIES">
      <data key="d0">PROTEIN</data>
      <data key="d1">Anti-topoisomerase I antibodies are autoantibodies that target the enzyme topoisomerase I. These autoantibodies are associated with systemic sclerosis, an autoimmune disease characterized by the hardening and tightening of the skin and connective tissues.</data>
      <data key="d2">5639a5e5649646c1e4c8deb1e1f0a1b1,c89a7a896cf934207d874042e48857da</data>
    </node>
    <node id="PERIPHERAL BLOOD">
      <data key="d0">CELL_LINE</data>
      <data key="d1">Peripheral blood is the blood circulating in the body outside of the heart and lungs, often used for DNA extraction</data>
      <data key="d2">c89a7a896cf934207d874042e48857da</data>
    </node>
    <node id="HAPMAP">
      <data key="d0">CHEMICAL</data>
      <data key="d1">HapMap is a project that provides data on common genetic variants in human populations</data>
      <data key="d2">c89a7a896cf934207d874042e48857da</data>
    </node>
    <node id="LOGISTIC REGRESSION">
      <data key="d0">BIOLOGICALPATHWAY</data>
      <data key="d1">Logistic regression is a statistical method used to model the relationship between a dependent variable and one or more independent variables. It is particularly useful in medical research for estimating the risk of specific genetic markers, such as TNFSF4 SNPs, in diseases like systemic sclerosis (SSc). Additionally, logistic regression can control for confounding variables, such as gender, to provide more accurate risk assessments.</data>
      <data key="d2">ab372f2a5df06a33e153fa648bb2b950,c89a7a896cf934207d874042e48857da</data>
    </node>
    <node id="HARDY&#8211;WEINBERG EQUILIBRIUM">
      <data key="d0">BIOLOGICALPATHWAY</data>
      <data key="d1">Hardy&#8211;Weinberg equilibrium is a principle that describes the genetic variation in a population under ideal conditions</data>
      <data key="d2">c89a7a896cf934207d874042e48857da</data>
    </node>
    <node id="LINKAGE DISEQUILIBRIUM">
      <data key="d0">BIOLOGICALPATHWAY</data>
      <data key="d1">Linkage disequilibrium refers to the non-random association of alleles at different loci in a given population.</data>
      <data key="d2">ab372f2a5df06a33e153fa648bb2b950,c89a7a896cf934207d874042e48857da</data>
    </node>
    <node id="HAPLOTYPE">
      <data key="d0">BIOLOGICALPATHWAY</data>
      <data key="d1">A haplotype is a group of genes within an organism that was inherited together from a single parent</data>
      <data key="d2">c89a7a896cf934207d874042e48857da</data>
    </node>
    <node id="OMNIBUS TEST">
      <data key="d0">BIOLOGICALPATHWAY</data>
      <data key="d1">Omnibus test is a statistical test used to detect differences in overall haplotype frequency profiles between groups</data>
      <data key="d2">c89a7a896cf934207d874042e48857da</data>
    </node>
    <node id="LSSC">
      <data key="d0">DISEASE</data>
      <data key="d1">Limited systemic sclerosis (LSSC) is a subset of systemic sclerosis characterized by limited cutaneous involvement. This condition, which falls under the broader category of systemic sclerosis, primarily affects the skin but can also have systemic implications.</data>
      <data key="d2">31513af83d109f0e11eca33fa5fb3204,ab372f2a5df06a33e153fa648bb2b950</data>
    </node>
    <node id="DSSC">
      <data key="d0">DISEASE</data>
      <data key="d1">Diffuse systemic sclerosis (DSSC) is a subset of systemic sclerosis (SSc) characterized by extensive cutaneous involvement. This condition is marked by widespread skin thickening and hardening, which can lead to significant functional impairment and disfigurement. DSSC is distinguished from other forms of systemic sclerosis by the severity and extent of skin involvement, often affecting large areas of the body.</data>
      <data key="d2">31513af83d109f0e11eca33fa5fb3204,ab372f2a5df06a33e153fa648bb2b950</data>
    </node>
    <node id="ACA">
      <data key="d0">PROTEIN</data>
      <data key="d1">Anti-centromere antibodies, associated with a subset of systemic sclerosis</data>
      <data key="d2">31513af83d109f0e11eca33fa5fb3204</data>
    </node>
    <node id="ATA">
      <data key="d0">PROTEIN</data>
      <data key="d1">Anti-topoisomerase antibodies, associated with a subset of systemic sclerosis</data>
      <data key="d2">31513af83d109f0e11eca33fa5fb3204</data>
    </node>
    <node id="ARA">
      <data key="d0">PROTEIN</data>
      <data key="d1">Anti-RNA polymerase III antibodies, associated with a subset of systemic sclerosis</data>
      <data key="d2">31513af83d109f0e11eca33fa5fb3204</data>
    </node>
    <node id="PULMONARY HYPERTENSION">
      <data key="d0">DISEASE</data>
      <data key="d1">Pulmonary hypertension, a type of high blood pressure that affects the arteries in the lungs and the right side of the heart, often associated with systemic sclerosis</data>
      <data key="d2">31513af83d109f0e11eca33fa5fb3204</data>
    </node>
    <node id="C-G-A-A-C">
      <data key="d0">SNP</data>
      <data key="d1">A specific 5-marker haplotype in the TNFSF4 gene associated with systemic sclerosis risk</data>
      <data key="d2">31513af83d109f0e11eca33fa5fb3204</data>
    </node>
    <node id="G-G-C-G-C">
      <data key="d0">SNP</data>
      <data key="d1">A specific 5-marker haplotype in the TNFSF4 gene associated with systemic sclerosis risk</data>
      <data key="d2">31513af83d109f0e11eca33fa5fb3204</data>
    </node>
    <node id="G-G-C-G-T">
      <data key="d0">SNP</data>
      <data key="d1">A specific 5-marker haplotype in the TNFSF4 gene associated with systemic sclerosis risk</data>
      <data key="d2">31513af83d109f0e11eca33fa5fb3204</data>
    </node>
    <node id="G-T-C-G-C">
      <data key="d0">SNP</data>
      <data key="d1">A specific 5-marker haplotype in the TNFSF4 gene associated with systemic sclerosis risk</data>
      <data key="d2">31513af83d109f0e11eca33fa5fb3204</data>
    </node>
    <node id="C-G-A-G-C">
      <data key="d0">SNP</data>
      <data key="d1">A specific 5-marker haplotype in the TNFSF4 gene found to be protective against systemic sclerosis</data>
      <data key="d2">31513af83d109f0e11eca33fa5fb3204</data>
    </node>
    <node id="PULMONARY FIBROSIS">
      <data key="d0" />
      <data key="d1" />
      <data key="d2">31513af83d109f0e11eca33fa5fb3204</data>
    </node>
    <node id="GENDER">
      <data key="d0" />
      <data key="d1">Gender is controlled for in logistic regression analysis of TNFSF4 SNPs in systemic sclerosis (SSc).</data>
      <data key="d2">31513af83d109f0e11eca33fa5fb3204,ab372f2a5df06a33e153fa648bb2b950</data>
    </node>
    <node id="RS855648">
      <data key="d0">SNP</data>
      <data key="d1">Single nucleotide polymorphism rs855648 of the TNFSF4 gene is associated with systemic sclerosis</data>
      <data key="d2">5db9eda60231516215dcb8b82826f9bc,ab372f2a5df06a33e153fa648bb2b950</data>
    </node>
    <node id="SYSTEMIC SCLEROSIS">
      <data key="d0">DISEASE</data>
      <data key="d1">Systemic sclerosis, also known as scleroderma or SSc, is a chronic autoimmune disease characterized by fibrosis of the skin and internal organs.</data>
      <data key="d2">5db9eda60231516215dcb8b82826f9bc,f286191a8009d9c0ef61d3de0938f0e6</data>
    </node>
    <node id="ANTI-CENTROMERE">
      <data key="d0">PROTEIN</data>
      <data key="d1">Anti-centromere antibodies are associated with systemic sclerosis. These antibodies target centromere proteins and are commonly found in patients with this autoimmune disease.</data>
      <data key="d2">5db9eda60231516215dcb8b82826f9bc,e2d4a3467d27e6de3b2eea8b20f310e8</data>
      <data key="d3">PROTEIN</data>
    </node>
    <node id="ANTI-TOPOISOMERASE I">
      <data key="d0">PROTEIN</data>
      <data key="d1">Anti-topoisomerase I antibodies are associated with systemic sclerosis. These antibodies target topoisomerase I, an enzyme involved in DNA replication and repair, and their presence is a significant marker for the diagnosis and prognosis of systemic sclerosis.</data>
      <data key="d2">5db9eda60231516215dcb8b82826f9bc,ab372f2a5df06a33e153fa648bb2b950,e2d4a3467d27e6de3b2eea8b20f310e8</data>
      <data key="d3">PROTEIN</data>
    </node>
    <node id="ANTI-RNA POLYMERASE III">
      <data key="d0">PROTEIN</data>
      <data key="d1">Anti-RNA polymerase III antibodies are autoantibodies associated with systemic sclerosis. These antibodies target RNA polymerase III and are commonly found in patients with this autoimmune disease.</data>
      <data key="d2">5db9eda60231516215dcb8b82826f9bc,ab372f2a5df06a33e153fa648bb2b950,e2d4a3467d27e6de3b2eea8b20f310e8</data>
      <data key="d3">PROTEIN</data>
    </node>
    <node id="LIMITED SYSTEMIC SCLEROSIS">
      <data key="d0">DISEASE</data>
      <data key="d1">A subtype of systemic sclerosis characterized by limited skin involvement</data>
      <data key="d2">e2d4a3467d27e6de3b2eea8b20f310e8</data>
      <data key="d3">DISEASE</data>
    </node>
    <node id="DIFFUSE SYSTEMIC SCLEROSIS">
      <data key="d0">DISEASE</data>
      <data key="d1">A subtype of systemic sclerosis characterized by widespread skin involvement</data>
      <data key="d2">e2d4a3467d27e6de3b2eea8b20f310e8</data>
      <data key="d3">DISEASE</data>
    </node>
    <node id="RS944648">
      <data key="d0">SNP</data>
      <data key="d1">Single nucleotide polymorphism rs944648 is associated with systemic sclerosis. There appears to be conflicting information regarding the gene in which this SNP is located, with some sources attributing it to the AIF1 gene and others to the TNFSF4 gene. Further research is needed to clarify the exact genetic context of rs944648 in relation to systemic sclerosis.</data>
      <data key="d2">5639a5e5649646c1e4c8deb1e1f0a1b1,ab372f2a5df06a33e153fa648bb2b950,f286191a8009d9c0ef61d3de0938f0e6</data>
    </node>
    <node id="MHC CLASS II">
      <data key="d0">GENE</data>
      <data key="d1">Major histocompatibility complex class II, a gene associated with SSc susceptibilityMajor histocompatibility complex class II, a gene associated with systemic sclerosis susceptibility</data>
      <data key="d2">ab372f2a5df06a33e153fa648bb2b950</data>
      <data key="d3">GENE</data>
    </node>
    <node id="AIF1">
      <data key="d0">GENE</data>
      <data key="d1">AIF1, also known as Allograft Inflammatory Factor 1, is a gene associated with systemic sclerosis (SSc) susceptibility. It plays a significant role in the immune response and inflammation, making it a critical factor in the study of autoimmune diseases.</data>
      <data key="d2">ab372f2a5df06a33e153fa648bb2b950,f286191a8009d9c0ef61d3de0938f0e6</data>
      <data key="d3">GENE</data>
    </node>
    <node id="T CELL">
      <data key="d0">CELL_LINE</data>
      <data key="d1">T cells are crucial components of the immune response, playing a significant role in the body's defense mechanisms. Their survival is notably enhanced by the costimulatory signal from the OX40/OX40L interaction. This interaction not only promotes T cell survival but also influences their overall function and effectiveness in the immune response.</data>
      <data key="d2">ab372f2a5df06a33e153fa648bb2b950,f286191a8009d9c0ef61d3de0938f0e6</data>
      <data key="d3">CELL_LINE</data>
    </node>
    <node id="B CELL">
      <data key="d0">CELL_LINE</data>
      <data key="d1">B cells are crucial components of the immune system, primarily involved in antibody production. Their proliferation and differentiation are significantly enhanced by the interaction between OX40 and OX40L. This OX40/OX40L interaction plays a pivotal role in modulating B cell functions, thereby influencing the overall immune response.</data>
      <data key="d2">ab372f2a5df06a33e153fa648bb2b950,f286191a8009d9c0ef61d3de0938f0e6</data>
      <data key="d3">CELL_LINE</data>
    </node>
    <node id="NK CELL">
      <data key="d0">CELL_LINE</data>
      <data key="d1">Natural killer cells are part of the immune system and express OX40L</data>
      <data key="d2">ab372f2a5df06a33e153fa648bb2b950</data>
      <data key="d3">CELL_LINE</data>
    </node>
    <node id="ENDOTHELIAL CELL">
      <data key="d0">CELL_LINE</data>
      <data key="d1">Endothelial cells are non-immune cells that express OX40L</data>
      <data key="d2">ab372f2a5df06a33e153fa648bb2b950</data>
      <data key="d3">CELL_LINE</data>
    </node>
    <node id="SMOOTH MUSCLE CELL">
      <data key="d0">CELL_LINE</data>
      <data key="d1">Smooth muscle cells are non-immune cells that express OX40L</data>
      <data key="d2">ab372f2a5df06a33e153fa648bb2b950</data>
      <data key="d3">CELL_LINE</data>
    </node>
    <node id="CD4+ T CELL">
      <data key="d0">CELL_LINE</data>
      <data key="d1">CD4+ T cells express OX40 and are involved in the immune response</data>
      <data key="d2">ab372f2a5df06a33e153fa648bb2b950</data>
      <data key="d3">CELL_LINE</data>
    </node>
    <node id="CD8+ T CELL">
      <data key="d0">CELL_LINE</data>
      <data key="d1">CD8+ T cells express OX40 and are involved in the immune response</data>
      <data key="d2">ab372f2a5df06a33e153fa648bb2b950</data>
      <data key="d3">CELL_LINE</data>
    </node>
    <node id="TH2">
      <data key="d0">BIOLOGICALPATHWAY</data>
      <data key="d1">T helper 2 cytokines are preferentially promoted by OX40&#8211;OX40L interactionT helper 2 (Th2) response is induced by OX40L alone</data>
      <data key="d2">ab372f2a5df06a33e153fa648bb2b950</data>
      <data key="d3">BIOLOGICALPATHWAY</data>
    </node>
    <node id="IL-17">
      <data key="d0">CHEMICAL</data>
      <data key="d1">IL-17 is a pro-inflammatory cytokine whose production is regulated by the interaction between OX40 and OX40L. Specifically, Interleukin 17 (IL-17) production is negatively regulated by the OX40&#8211;OX40L interaction.</data>
      <data key="d2">ab372f2a5df06a33e153fa648bb2b950,f286191a8009d9c0ef61d3de0938f0e6</data>
      <data key="d3">CHEMICAL</data>
    </node>
    <node id="FOXP3+ REGULATORY T CELL">
      <data key="d0">CELL_LINE</data>
      <data key="d1">Foxp3+ regulatory T cells are inhibited by OX40&#8211;OX40L interactions</data>
      <data key="d2">ab372f2a5df06a33e153fa648bb2b950</data>
      <data key="d3">CELL_LINE</data>
    </node>
    <node id="DIABETES">
      <data key="d0">DISEASE</data>
      <data key="d1">Diabetes is a chronic disease characterized by high blood sugar levels. It is a condition where targeted strategies to block OX40&#8211;OX40L interactions have shown preventive effects.</data>
      <data key="d2">ab372f2a5df06a33e153fa648bb2b950,f286191a8009d9c0ef61d3de0938f0e6</data>
      <data key="d3">DISEASE</data>
    </node>
    <node id="EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS">
      <data key="d0">DISEASE</data>
      <data key="d1">Experimental autoimmune encephalomyelitis is an animal model of multiple sclerosis. In this model, blocking OX40&#8211;OX40L interactions has shown preventive effects, making it a valuable tool for studying potential therapeutic interventions for multiple sclerosis.</data>
      <data key="d2">ab372f2a5df06a33e153fa648bb2b950,f286191a8009d9c0ef61d3de0938f0e6</data>
      <data key="d3">DISEASE</data>
    </node>
    <node id="MULTIPLE SCLEROSIS">
      <data key="d0">DISEASE</data>
      <data key="d1">Multiple sclerosis is an autoimmune disease where blocking OX40&#8211;OX40L interactions has shown preventive effects</data>
      <data key="d2">ab372f2a5df06a33e153fa648bb2b950</data>
      <data key="d3">DISEASE</data>
    </node>
    <node id="C57/BL6">
      <data key="d0">CELL_LINE</data>
      <data key="d1">C57/BL6 is a mouse strain used in studies of OX40L transgenic mice</data>
      <data key="d2">ab372f2a5df06a33e153fa648bb2b950</data>
      <data key="d3">CELL_LINE</data>
    </node>
    <node id="AUTOIMMUNITY">
      <data key="d0">DISEASE</data>
      <data key="d1">Autoimmunity involves immune system attacks on the body's own tissues, potentially regulated by OX40&#8211;OX40L interactions</data>
      <data key="d2">ab372f2a5df06a33e153fa648bb2b950</data>
      <data key="d3">DISEASE</data>
    </node>
    <node id="NORTH AMERICAN CAUCASIANS">
      <data key="d0">CELL_LINE</data>
      <data key="d1">North American Caucasians are the population studied for the association of TNFSF4 polymorphisms with SScNorth American Caucasians are the population studied for the association of TNFSF4 polymorphisms with systemic sclerosis</data>
      <data key="d2">ab372f2a5df06a33e153fa648bb2b950</data>
      <data key="d3">CELL_LINE</data>
    </node>
    <node id="AUTOANTIBODY">
      <data key="d0">CHEMICAL</data>
      <data key="d1">Autoantibodies are associated with systemic sclerosis and its subsetsAutoantibodies are associated with SSc and its subsets</data>
      <data key="d2">ab372f2a5df06a33e153fa648bb2b950</data>
      <data key="d3">CHEMICAL</data>
    </node>
    <node id="BENJAMINI AND HOCHBERG FALSE DISCOVERY RATE METHOD">
      <data key="d0">BIOLOGICALPATHWAY</data>
      <data key="d1">A statistical method used to correct p values</data>
      <data key="d2">ab372f2a5df06a33e153fa648bb2b950</data>
    </node>
    <node id="&#935;2">
      <data key="d0">BIOLOGICALPATHWAY</data>
      <data key="d1">Chi-squared test is used to calculate raw p values</data>
      <data key="d2">ab372f2a5df06a33e153fa648bb2b950</data>
    </node>
    <node id="D&#8217;">
      <data key="d0">BIOLOGICALPATHWAY</data>
      <data key="d1">Disequilibrium coefficient used to measure linkage disequilibrium between SNPs</data>
      <data key="d2">ab372f2a5df06a33e153fa648bb2b950</data>
    </node>
    <node id="R">
      <data key="d0">BIOLOGICALPATHWAY</data>
      <data key="d1">r values measure the strength of linkage disequilibrium between SNPsA measure of strength of linkage disequilibrium between SNPs</data>
      <data key="d2">ab372f2a5df06a33e153fa648bb2b950</data>
      <data key="d3">BIOLOGICALPATHWAY</data>
    </node>
    <node id="HAPLOTYPE BLOCK">
      <data key="d0">BIOLOGICALPATHWAY</data>
      <data key="d1">Haplotype block structure refers to regions of the genome where genetic variations are inherited togetherA region of the genome where genetic variations are inherited together</data>
      <data key="d2">ab372f2a5df06a33e153fa648bb2b950</data>
      <data key="d3">BIOLOGICALPATHWAY</data>
    </node>
    <node id="DENDRITIC CELL">
      <data key="d0">CELL_LINE</data>
      <data key="d1">Dendritic cells are unleashed after T-reg cell inactivation, allowing them to induce an adaptive immune response. Additionally, dendritic cells express OX40L and regulate T helper responses.</data>
      <data key="d2">ab372f2a5df06a33e153fa648bb2b950,f286191a8009d9c0ef61d3de0938f0e6</data>
      <data key="d3">CELL_LINE</data>
    </node>
    <node id="MACROPHAGE">
      <data key="d0">CELL_LINE</data>
      <data key="d1">Macrophages express OX40L and are involved in immune responses</data>
      <data key="d2">ab372f2a5df06a33e153fa648bb2b950</data>
      <data key="d3">CELL_LINE</data>
    </node>
    <node id="OX40">
      <data key="d0" />
      <data key="d1">OX40 is a co-stimulatory T-cell receptor and a member of the tumor necrosis factor (TNF) receptor superfamily. It plays a central role in the pathogenesis of atopic dermatitis and other autoimmune and inflammatory conditions. The OX40 gene encodes a protein that is crucial for T cell costimulatory signaling, promoting T cell activation, survival, and proliferation. This protein binds to OX40L, generating a potent costimulatory signal essential for T cell function. OX40 is highly expressed by skin-homing T cells and monocytes in patients with atopic dermatitis, highlighting its significant role in the disease's pathology.</data>
      <data key="d2">05fe283d6fa879523f3ab153815ac64b,2712037f85fc28b3e86b92a719cb7a6c,2f4bf4583547aaf1c5cc6eaea0b058eb,7a1160d4230f62889d47499ed90adcdd,919f7083e77a7d3378489efeffa0faed,a98a120ac25d0f8a533fcdcd479913b1,ab372f2a5df06a33e153fa648bb2b950,f286191a8009d9c0ef61d3de0938f0e6</data>
    </node>
    <node id="PFDR">
      <data key="d0">BIOLOGICALPATHWAY</data>
      <data key="d1">pFDR refers to corrected p values using the Benjamini and Hochberg false discovery rate method</data>
      <data key="d2">ab372f2a5df06a33e153fa648bb2b950</data>
    </node>
    <node id="PU">
      <data key="d0">BIOLOGICALPATHWAY</data>
      <data key="d1">pU refers to raw chi-squared p values</data>
      <data key="d2">ab372f2a5df06a33e153fa648bb2b950</data>
    </node>
    <node id="LD">
      <data key="d0">BIOLOGICALPATHWAY</data>
      <data key="d1">Linkage disequilibrium (LD) refers to the non-random association of alleles at different loci</data>
      <data key="d2">ab372f2a5df06a33e153fa648bb2b950</data>
    </node>
    <node id="D'">
      <data key="d0">BIOLOGICALPATHWAY</data>
      <data key="d1">Disequilibrium coefficient D' measures the strength of linkage disequilibrium between SNPs</data>
      <data key="d2">ab372f2a5df06a33e153fa648bb2b950</data>
    </node>
    <node id="TH1">
      <data key="d0">BIOLOGICALPATHWAY</data>
      <data key="d1">T helper 1 (Th1) response is induced by OX40L in combination with type I interferon</data>
      <data key="d2">ab372f2a5df06a33e153fa648bb2b950</data>
    </node>
    <node id="CTLA4">
      <data key="d0">GENE</data>
      <data key="d1">CTLA4 is a gene associated with rheumatoid arthritis</data>
      <data key="d2">5639a5e5649646c1e4c8deb1e1f0a1b1</data>
    </node>
    <node id="PADI4">
      <data key="d0">GENE</data>
      <data key="d1">PADI4 is a gene associated with rheumatoid arthritis</data>
      <data key="d2">5639a5e5649646c1e4c8deb1e1f0a1b1</data>
    </node>
    <node id="BANK1">
      <data key="d0">GENE</data>
      <data key="d1">BANK1 is a gene associated with systemic lupus erythematosus</data>
      <data key="d2">5639a5e5649646c1e4c8deb1e1f0a1b1</data>
    </node>
    <node id="RHEUMATOID ARTHRITIS">
      <data key="d0" />
      <data key="d1">Rheumatoid arthritis is an autoimmune disease characterized by chronic inflammation of the joints. This condition involves the immune system mistakenly attacking the body's own tissues, leading to persistent joint inflammation, pain, and potential joint damage.</data>
      <data key="d2">2712037f85fc28b3e86b92a719cb7a6c,5639a5e5649646c1e4c8deb1e1f0a1b1</data>
      <data key="d3">DISEASE</data>
    </node>
    <node id="TYPE I DIABETES">
      <data key="d0" />
      <data key="d1" />
      <data key="d2">5639a5e5649646c1e4c8deb1e1f0a1b1</data>
    </node>
    <node id="TYPE 1A DIABETES">
      <data key="d0">DISEASE</data>
      <data key="d1">Type 1A diabetes, an autoimmune disease</data>
      <data key="d2">5639a5e5649646c1e4c8deb1e1f0a1b1</data>
    </node>
    <node id="ATHEROTHROMBOSIS">
      <data key="d0">DISEASE</data>
      <data key="d1">Atherothrombosis, a cardiovascular disease</data>
      <data key="d2">5639a5e5649646c1e4c8deb1e1f0a1b1</data>
    </node>
    <node id="VENOUS THROMBOEMBOLISM">
      <data key="d0">DISEASE</data>
      <data key="d1">Venous thromboembolism, a condition involving blood clots in veins</data>
      <data key="d2">5639a5e5649646c1e4c8deb1e1f0a1b1</data>
    </node>
    <node id="CAROTID ARTERY DISEASE">
      <data key="d0">DISEASE</data>
      <data key="d1">Carotid artery disease, a condition affecting the carotid arteries</data>
      <data key="d2">5639a5e5649646c1e4c8deb1e1f0a1b1</data>
    </node>
    <node id="STROKE">
      <data key="d0">DISEASE</data>
      <data key="d1">Stroke, a condition where blood flow to the brain is interrupted</data>
      <data key="d2">5639a5e5649646c1e4c8deb1e1f0a1b1</data>
    </node>
    <node id="CREST SYNDROME">
      <data key="d0">DISEASE</data>
      <data key="d1">CREST syndrome is a subtype of systemic sclerosis characterized by Calcinosis, Raynaud's phenomenon, Esophageal dysmotility, Sclerodactyly, and Telangiectasia.</data>
      <data key="d2">5639a5e5649646c1e4c8deb1e1f0a1b1,f286191a8009d9c0ef61d3de0938f0e6</data>
    </node>
    <node id="ANTI-RNP ANTIBODIES">
      <data key="d0">PROTEIN</data>
      <data key="d1">Anti-RNP antibodies, autoantibodies associated with systemic lupus erythematosus</data>
      <data key="d2">5639a5e5649646c1e4c8deb1e1f0a1b1</data>
    </node>
    <node id="FIBRILLARIN">
      <data key="d0">PROTEIN</data>
      <data key="d1">Fibrillarin, a protein targeted by autoantibodies in systemic sclerosis</data>
      <data key="d2">5639a5e5649646c1e4c8deb1e1f0a1b1</data>
    </node>
    <node id="INTERFERON">
      <data key="d0">PROTEIN</data>
      <data key="d1">Interferon, a protein involved in immune response, associated with systemic lupus erythematosus</data>
      <data key="d2">5639a5e5649646c1e4c8deb1e1f0a1b1</data>
    </node>
    <node id="IRF5 RS2004640">
      <data key="d0">SNP</data>
      <data key="d1">IRF5 rs2004640, a functional polymorphism associated with systemic sclerosis and systemic lupus erythematosus</data>
      <data key="d2">5639a5e5649646c1e4c8deb1e1f0a1b1</data>
    </node>
    <node id="FAS -670G&gt;A">
      <data key="d0">SNP</data>
      <data key="d1">FAS -670G&gt;A, a polymorphism in the FAS gene promoter region influencing susceptibility to systemic sclerosis</data>
      <data key="d2">5639a5e5649646c1e4c8deb1e1f0a1b1</data>
    </node>
    <node id="SCLERODERMA">
      <data key="d0">DISEASE</data>
      <data key="d1">Scleroderma, also referred to as systemic sclerosis, involves the hardening and tightening of the skin and connective tissues</data>
      <data key="d2">f286191a8009d9c0ef61d3de0938f0e6</data>
    </node>
    <node id="ANTICENTROMERE ANTIBODIES">
      <data key="d0">PROTEIN</data>
      <data key="d1">Anticentromere antibodies are autoantibodies associated with CREST syndrome and systemic sclerosis</data>
      <data key="d2">f286191a8009d9c0ef61d3de0938f0e6</data>
    </node>
    <node id="TNF">
      <data key="d0">GENE</data>
      <data key="d1">Tumor Necrosis Factor (TNF) is a cytokine involved in systemic inflammation and is a member of a group of cytokines that stimulate the acute phase reaction. It is also a gene that is part of the TNF superfamily, playing a crucial role in the body's immune response.</data>
      <data key="d2">2712037f85fc28b3e86b92a719cb7a6c,f286191a8009d9c0ef61d3de0938f0e6</data>
    </node>
    <node id="T-REG CELL">
      <data key="d0">CELL_LINE</data>
      <data key="d1">T-reg cell function is inactivated by OX40, unleashing nearby dendritic cells</data>
      <data key="d2">f286191a8009d9c0ef61d3de0938f0e6</data>
    </node>
    <node id="HLA-DQB1">
      <data key="d0">GENE</data>
      <data key="d1">HLA-DQB1 is a gene associated with the immune response and is linked to anti-topoisomerase I autoantibody response in scleroderma</data>
      <data key="d2">f286191a8009d9c0ef61d3de0938f0e6</data>
    </node>
    <node id="ANTI-TOPOISOMERASE I AUTOANTIBODY">
      <data key="d0">PROTEIN</data>
      <data key="d1">Anti-topoisomerase I autoantibody is an autoantibody associated with scleroderma</data>
      <data key="d2">f286191a8009d9c0ef61d3de0938f0e6</data>
    </node>
    <node id="NOD MICE">
      <data key="d0">CELL_LINE</data>
      <data key="d1">NOD mice are a strain of mice used as a model for studying autoimmune diseases, including diabetes</data>
      <data key="d2">f286191a8009d9c0ef61d3de0938f0e6</data>
    </node>
    <node id="ANTI-OX40 LIGAND MONOCLONAL ANTIBODY">
      <data key="d0">DRUG</data>
      <data key="d1">Anti-OX40 ligand monoclonal antibody is a therapeutic agent used to target OX40/OX40L interactions</data>
      <data key="d2">f286191a8009d9c0ef61d3de0938f0e6</data>
    </node>
    <node id="TH-2 CELLS">
      <data key="d0">CELL_LINE</data>
      <data key="d1">Th-2 cells are a subset of T helper cells involved in the immune response</data>
      <data key="d2">f286191a8009d9c0ef61d3de0938f0e6</data>
    </node>
    <node id="FOX P3+ REGULATORY T-CELLS">
      <data key="d0">CELL_LINE</data>
      <data key="d1">Foxp3+ regulatory T-cells are a subset of T cells involved in maintaining immune tolerance</data>
      <data key="d2">f286191a8009d9c0ef61d3de0938f0e6</data>
    </node>
    <node id="TYPE I IFNS">
      <data key="d0">CHEMICAL</data>
      <data key="d1">Type I interferons are cytokines involved in the regulation of immune responses</data>
      <data key="d2">f286191a8009d9c0ef61d3de0938f0e6</data>
    </node>
    <node id="MEMORY T-CELLS">
      <data key="d0">CELL_LINE</data>
      <data key="d1">Memory T-cells are a subset of T cells that provide long-term immunity</data>
      <data key="d2">f286191a8009d9c0ef61d3de0938f0e6</data>
    </node>
    <node id="ALLOANTIBODY">
      <data key="d0">PROTEIN</data>
      <data key="d1">Alloantibodies are antibodies produced in response to alloantigens, often following repeated alloimmunizations</data>
      <data key="d2">f286191a8009d9c0ef61d3de0938f0e6</data>
    </node>
    <node id="PLASMACYTOID DENDRITIC CELLS">
      <data key="d0">CELL_LINE</data>
      <data key="d1">Plasmacytoid dendritic cells are a type of dendritic cell involved in regulating T cell responses</data>
      <data key="d2">f286191a8009d9c0ef61d3de0938f0e6</data>
    </node>
    <node id="TH CELL">
      <data key="d0">CELL_LINE</data>
      <data key="d1">Th cells are a type of T helper cell involved in the immune response</data>
      <data key="d2">f286191a8009d9c0ef61d3de0938f0e6</data>
    </node>
    <node id="BLADDER CANCER">
      <data key="d0">DISEASE</data>
      <data key="d1">Bladder cancer is a type of cancer that begins in the cells of the bladder</data>
      <data key="d2">f286191a8009d9c0ef61d3de0938f0e6</data>
    </node>
    <node id="DNA-REPAIR GENES">
      <data key="d0">GENE</data>
      <data key="d1">DNA-repair genes are involved in the repair of DNA damage and are linked to cancer predisposition</data>
      <data key="d2">f286191a8009d9c0ef61d3de0938f0e6</data>
    </node>
    <node id="CELL-CYCLE-CONTROL GENES">
      <data key="d0">GENE</data>
      <data key="d1">Cell-cycle-control genes regulate the cell cycle and are associated with cancer predisposition</data>
      <data key="d2">f286191a8009d9c0ef61d3de0938f0e6</data>
    </node>
    <node id="FAMILIAL SYSTEMIC SCLEROSIS">
      <data key="d0">DISEASE</data>
      <data key="d1">Familial systemic sclerosis is a form of systemic sclerosis that occurs in families, indicating a genetic component</data>
      <data key="d2">f286191a8009d9c0ef61d3de0938f0e6</data>
    </node>
    <node id="ANTI-NUCLEAR ANTIBODY">
      <data key="d0">PROTEIN</data>
      <data key="d1">Anti-nuclear antibodies are autoantibodies that target the cell nucleus and are often found in systemic sclerosis patients</data>
      <data key="d2">f286191a8009d9c0ef61d3de0938f0e6</data>
    </node>
    <node id="OX40/OX40L INTERACTION">
      <data key="d0">BIOLOGICALPATHWAY</data>
      <data key="d1">OX40/OX40L interaction is a costimulatory signal crucial for T cell and B cell function</data>
      <data key="d2">f286191a8009d9c0ef61d3de0938f0e6</data>
    </node>
    <node id="TH-2 PRIMING">
      <data key="d0">BIOLOGICALPATHWAY</data>
      <data key="d1">Th-2 priming is the process of activating Th-2 cells, which is influenced by OX40 ligand</data>
      <data key="d2">f286191a8009d9c0ef61d3de0938f0e6</data>
    </node>
    <node id="MEMORY INDUCTION">
      <data key="d0">BIOLOGICALPATHWAY</data>
      <data key="d1">Memory induction is the process of forming long-lasting immune memory, influenced by OX40 ligand</data>
      <data key="d2">f286191a8009d9c0ef61d3de0938f0e6</data>
    </node>
    <node id="PATHOGENIC TH-2 CELLS">
      <data key="d0">CELL_LINE</data>
      <data key="d1">Pathogenic Th-2 cells are a subset of T helper cells involved in allergic responses and asthma</data>
      <data key="d2">f286191a8009d9c0ef61d3de0938f0e6</data>
    </node>
    <node id="AUTOIMMUNE-LIKE DISEASES">
      <data key="d0">DISEASE</data>
      <data key="d1">Autoimmune-like diseases are conditions that resemble autoimmune diseases, induced by constitutive OX40/OX40 ligand interaction</data>
      <data key="d2">f286191a8009d9c0ef61d3de0938f0e6</data>
    </node>
    <node id="SERUM SOLUBLE OX40">
      <data key="d0">PROTEIN</data>
      <data key="d1">Serum soluble OX40 is a form of OX40 found in the blood of systemic sclerosis patients</data>
      <data key="d2">f286191a8009d9c0ef61d3de0938f0e6</data>
    </node>
    <node id="PROGRESSIVE SYSTEMIC SCLEROSIS">
      <data key="d0">DISEASE</data>
      <data key="d1">Progressive systemic sclerosis is a severe form of systemic sclerosis characterized by rapid progression and extensive fibrosis</data>
      <data key="d2">f286191a8009d9c0ef61d3de0938f0e6</data>
    </node>
    <node id="ANGIOGENESIS">
      <data key="d0" />
      <data key="d1" />
      <data key="d2">f286191a8009d9c0ef61d3de0938f0e6</data>
    </node>
    <node id="ATOPIC DERMATITIS">
      <data key="d0">DISEASE</data>
      <data key="d1">Atopic dermatitis (AD) is a chronic, or chronically relapsing, inflammatory skin disease associated with asthma and allergic rhinitis, dominated by Th2 cells</data>
      <data key="d2">a98a120ac25d0f8a533fcdcd479913b1</data>
    </node>
    <node id="ASTHMA">
      <data key="d0">DISEASE</data>
      <data key="d1">Asthma is a chronic respiratory condition characterized by airway inflammation and hyperreactivity. It is a chronic inflammatory disease of the airways that causes breathing difficulties. Asthma is also commonly associated with atopic dermatitis, making it a frequent comorbidity in patients with this skin condition.</data>
      <data key="d2">05fe283d6fa879523f3ab153815ac64b,2712037f85fc28b3e86b92a719cb7a6c,7a1160d4230f62889d47499ed90adcdd,919f7083e77a7d3378489efeffa0faed,a98a120ac25d0f8a533fcdcd479913b1</data>
    </node>
    <node id="ALLERGIC RHINITIS">
      <data key="d0">DISEASE</data>
      <data key="d1">Allergic rhinitis is an allergic reaction that causes sneezing, congestion, and a runny nose. It is often associated with atopic dermatitis.</data>
      <data key="d2">7a1160d4230f62889d47499ed90adcdd,a98a120ac25d0f8a533fcdcd479913b1</data>
    </node>
    <node id="TH2 CELLS">
      <data key="d0">CELL_LINE</data>
      <data key="d1">Th2 cells are a subset of T cells involved in the immune response, particularly in the context of allergies and asthma. They play a central role in the pathogenesis of atopic dermatitis by driving the inflammatory response.</data>
      <data key="d2">2712037f85fc28b3e86b92a719cb7a6c,a98a120ac25d0f8a533fcdcd479913b1</data>
    </node>
    <node id="SOX40">
      <data key="d0">PROTEIN</data>
      <data key="d1">Soluble OX40 (sOX40) is a form of the OX40 protein that is found in serum. It has an anti-inflammatory effect when binding to the membrane-bound form of OX40L. Soluble OX40 is associated with atopic comorbidities and disease activity in children and is measured in patients with atopic dermatitis. It plays a role in the immune response.</data>
      <data key="d2">05fe283d6fa879523f3ab153815ac64b,2f4bf4583547aaf1c5cc6eaea0b058eb,7a1160d4230f62889d47499ed90adcdd,919f7083e77a7d3378489efeffa0faed,a98a120ac25d0f8a533fcdcd479913b1</data>
    </node>
    <node id="CD4+ T CELLS">
      <data key="d0">CELL_LINE</data>
      <data key="d1">CD4+ T cells are a type of T cell that expresses OX40 and is involved in the immune response in atopic dermatitis</data>
      <data key="d2">a98a120ac25d0f8a533fcdcd479913b1</data>
    </node>
    <node id="IGE">
      <data key="d0">CHEMICAL</data>
      <data key="d1">Immunoglobulin E (IgE) is an antibody that is elevated in up to 80% of patients with atopic dermatitis and is involved in the interaction between mast cells and T cells. IgE is primarily associated with allergic reactions and is commonly measured in patients with atopic dermatitis. In the context of the study, IgE levels were measured but were not correlated with OX40 expression.</data>
      <data key="d2">05fe283d6fa879523f3ab153815ac64b,7a1160d4230f62889d47499ed90adcdd,919f7083e77a7d3378489efeffa0faed,a98a120ac25d0f8a533fcdcd479913b1</data>
    </node>
    <node id="MAST CELLS">
      <data key="d0">CELL_LINE</data>
      <data key="d1">Mast cells are immune cells involved in allergic reactions and inflammation. They release histamine and other substances during inflammatory and allergic reactions, a process confirmed by positive tryptase staining. In the context of atopic dermatitis (AD) patients, mast cells in the skin express OX40L, which is also confirmed by tryptase staining. Additionally, mast cells are involved in the production of Th2 driving cytokines such as IL-4 and IL-25, further contributing to their role in immune responses.</data>
      <data key="d2">2712037f85fc28b3e86b92a719cb7a6c,7a1160d4230f62889d47499ed90adcdd,919f7083e77a7d3378489efeffa0faed,a98a120ac25d0f8a533fcdcd479913b1</data>
    </node>
    <node id="IL-4">
      <data key="d0">CHEMICAL</data>
      <data key="d1">Interleukin-4 (IL-4) is a cytokine produced by mast cells that drives the Th2 response in atopic dermatitis</data>
      <data key="d2">a98a120ac25d0f8a533fcdcd479913b1</data>
    </node>
    <node id="IL-25">
      <data key="d0">CHEMICAL</data>
      <data key="d1">Interleukin-25 (IL-25) is a cytokine produced by mast cells that drives the Th2 response in atopic dermatitis</data>
      <data key="d2">a98a120ac25d0f8a533fcdcd479913b1</data>
    </node>
    <node id="SCORAD">
      <data key="d0">BIOLOGICALPATHWAY</data>
      <data key="d1">SCORAD, or SCORing Atopic Dermatitis, is a clinical tool used to assess the severity of atopic dermatitis. The SCORAD index provides a standardized method for evaluating the extent and intensity of the disease, incorporating both objective and subjective measures to offer a comprehensive assessment of the condition.</data>
      <data key="d2">05fe283d6fa879523f3ab153815ac64b,919f7083e77a7d3378489efeffa0faed,a98a120ac25d0f8a533fcdcd479913b1</data>
    </node>
    <node id="PBMCS">
      <data key="d0">CELL_LINE</data>
      <data key="d1">Peripheral Blood Mononuclear Cells (PBMCs) are a type of blood cell that is critical in immune response and are extensively used in various immunological studies. These cells play a significant role in immune response studies, particularly in the context of atopic dermatitis. PBMCs are utilized in immunophenotyping to study the expression of OX40 and OX40L, which are important markers in the pathology of atopic dermatitis.</data>
      <data key="d2">2f4bf4583547aaf1c5cc6eaea0b058eb,919f7083e77a7d3378489efeffa0faed,a98a120ac25d0f8a533fcdcd479913b1</data>
    </node>
    <node id="ECZEMA">
      <data key="d0">SYMPTOM</data>
      <data key="d1">Eczema is a symptom of atopic dermatitis characterized by inflamed, itchy, cracked, and rough skin</data>
      <data key="d2">a98a120ac25d0f8a533fcdcd479913b1</data>
    </node>
    <node id="PRURITUS">
      <data key="d0">SYMPTOM</data>
      <data key="d1">Pruritus is an intense itching sensation, a common symptom of atopic dermatitis</data>
      <data key="d2">a98a120ac25d0f8a533fcdcd479913b1</data>
    </node>
    <node id="DRY SKIN">
      <data key="d0">SYMPTOM</data>
      <data key="d1">Dry skin is a symptom of atopic dermatitis caused by profound skin inflammation and epidermal barrier dysfunction</data>
      <data key="d2">a98a120ac25d0f8a533fcdcd479913b1</data>
    </node>
    <node id="MEMORY T CELLS">
      <data key="d0">CELL_LINE</data>
      <data key="d1">Memory T cells are believed to be central for the chronicity of atopic dermatitis</data>
      <data key="d2">a98a120ac25d0f8a533fcdcd479913b1</data>
    </node>
    <node id="APC">
      <data key="d0">CELL_LINE</data>
      <data key="d1">Antigen-presenting cells (APC) express OX40L and are involved in the immune response in atopic dermatitis</data>
      <data key="d2">a98a120ac25d0f8a533fcdcd479913b1</data>
    </node>
    <node id="SOX40L">
      <data key="d0">PROTEIN</data>
      <data key="d1">Soluble OX40 Ligand (sOX40L) is a form of the OX40L protein that can be measured in serum. It is involved in the immune response and has the capability to bind to soluble OX40 (sOX40), exerting an anti-inflammatory effect. sOX40L has been studied in various contexts, including in patients with atopic dermatitis, although its levels were not found to be significantly different between groups in some studies.</data>
      <data key="d2">05fe283d6fa879523f3ab153815ac64b,2f4bf4583547aaf1c5cc6eaea0b058eb,7a1160d4230f62889d47499ed90adcdd,919f7083e77a7d3378489efeffa0faed,a98a120ac25d0f8a533fcdcd479913b1</data>
    </node>
    <node id="HANIFIN &amp; RAJKA CRITERIA">
      <data key="d0">BIOLOGICALPATHWAY</data>
      <data key="d1">The Hanifin &amp; Rajka criteria are used for diagnosing atopic dermatitis</data>
      <data key="d2">a98a120ac25d0f8a533fcdcd479913b1</data>
    </node>
    <node id="PLASMA">
      <data key="d0">CHEMICAL</data>
      <data key="d1">Plasma is the liquid component of blood, collected from patients for various analyses in atopic dermatitis studies</data>
      <data key="d2">a98a120ac25d0f8a533fcdcd479913b1</data>
    </node>
    <node id="AD">
      <data key="d0">DISEASE</data>
      <data key="d1">Atopic Dermatitis (AD) is a chronic inflammatory skin disease characterized by itchy and inflamed skin.</data>
      <data key="d2">05fe283d6fa879523f3ab153815ac64b,2712037f85fc28b3e86b92a719cb7a6c,2f4bf4583547aaf1c5cc6eaea0b058eb,7a1160d4230f62889d47499ed90adcdd,919f7083e77a7d3378489efeffa0faed</data>
    </node>
    <node id="HC">
      <data key="d0">CELL_LINE</data>
      <data key="d1">Healthy Controls (HC) are a group of individuals without atopic dermatitis, atopic diseases, or systemic inflammatory diseases, used as a comparison group in studies. These individuals serve as a baseline to help researchers understand the effects and characteristics of various conditions by providing a standard for comparison.</data>
      <data key="d2">05fe283d6fa879523f3ab153815ac64b,2f4bf4583547aaf1c5cc6eaea0b058eb,7a1160d4230f62889d47499ed90adcdd,919f7083e77a7d3378489efeffa0faed</data>
    </node>
    <node id="CD4">
      <data key="d0">PROTEIN</data>
      <data key="d1">CD4, a glycoprotein found on the surface of immune cells such as T helper cells, monocytes, macrophages, and dendritic cells</data>
      <data key="d2">2f4bf4583547aaf1c5cc6eaea0b058eb</data>
    </node>
    <node id="CD8">
      <data key="d0">PROTEIN</data>
      <data key="d1">CD8, a glycoprotein found on the surface of cytotoxic T cells, which are involved in the immune response</data>
      <data key="d2">2f4bf4583547aaf1c5cc6eaea0b058eb</data>
      <data key="d3">PROTEIN</data>
    </node>
    <node id="CD14">
      <data key="d0">PROTEIN</data>
      <data key="d1">CD14, a co-receptor for the detection of bacterial lipopolysaccharide, found on the surface of macrophages</data>
      <data key="d2">2f4bf4583547aaf1c5cc6eaea0b058eb</data>
      <data key="d3">PROTEIN</data>
    </node>
    <node id="CD45RO">
      <data key="d0">PROTEIN</data>
      <data key="d1">CD45RO, an isoform of the CD45 protein found on the surface of memory T cells</data>
      <data key="d2">2f4bf4583547aaf1c5cc6eaea0b058eb</data>
      <data key="d3">PROTEIN</data>
    </node>
    <node id="CD56">
      <data key="d0">PROTEIN</data>
      <data key="d1">CD56, a neural cell adhesion molecule found on the surface of natural killer cells and some T cells</data>
      <data key="d2">2f4bf4583547aaf1c5cc6eaea0b058eb</data>
      <data key="d3">PROTEIN</data>
    </node>
    <node id="CLA">
      <data key="d0">PROTEIN</data>
      <data key="d1">Cutaneous Lymphocyte Antigen, a protein involved in the homing of T cells to the skin</data>
      <data key="d2">2f4bf4583547aaf1c5cc6eaea0b058eb</data>
      <data key="d3">PROTEIN</data>
    </node>
    <node id="TRYPTASE">
      <data key="d0">PROTEIN</data>
      <data key="d1">Tryptase is a protease enzyme found in mast cells, playing a crucial role in allergic and inflammatory responses. It is often measured in studies related to atopic dermatitis to assess its involvement in these conditions. Additionally, tryptase is used to confirm the presence of mast cells, making it a significant marker in the study of allergic and inflammatory diseases.</data>
      <data key="d2">05fe283d6fa879523f3ab153815ac64b,2f4bf4583547aaf1c5cc6eaea0b058eb,7a1160d4230f62889d47499ed90adcdd</data>
      <data key="d3">PROTEIN</data>
    </node>
    <node id="FICOLL-PAQUE">
      <data key="d0">CHEMICAL</data>
      <data key="d1">Ficoll-Paque, a density gradient medium used for the isolation of PBMCs</data>
      <data key="d2">2f4bf4583547aaf1c5cc6eaea0b058eb</data>
      <data key="d3">CHEMICAL</data>
    </node>
    <node id="FORMALDEHYDE">
      <data key="d0">CHEMICAL</data>
      <data key="d1">Formaldehyde, a chemical used for tissue fixation in histology and pathology</data>
      <data key="d2">2f4bf4583547aaf1c5cc6eaea0b058eb</data>
      <data key="d3">CHEMICAL</data>
    </node>
    <node id="BOVINE SERUM ALBUMIN">
      <data key="d0">CHEMICAL</data>
      <data key="d1">Bovine Serum Albumin, a protein used in various laboratory procedures to stabilize enzymes and other proteins</data>
      <data key="d2">2f4bf4583547aaf1c5cc6eaea0b058eb</data>
      <data key="d3">CHEMICAL</data>
    </node>
    <node id="SODIUM AZIDE">
      <data key="d0">CHEMICAL</data>
      <data key="d1">Sodium Azide, a chemical used as a preservative in laboratory reagents</data>
      <data key="d2">2f4bf4583547aaf1c5cc6eaea0b058eb</data>
      <data key="d3">CHEMICAL</data>
    </node>
    <node id="PARAFFIN">
      <data key="d0">CHEMICAL</data>
      <data key="d1">Paraffin, a waxy substance used to embed tissue samples for histological analysis</data>
      <data key="d2">2f4bf4583547aaf1c5cc6eaea0b058eb</data>
      <data key="d3">CHEMICAL</data>
    </node>
    <node id="XYLENE">
      <data key="d0">CHEMICAL</data>
      <data key="d1">Xylene, a solvent used in the deparaffinization of tissue sections</data>
      <data key="d2">2f4bf4583547aaf1c5cc6eaea0b058eb</data>
      <data key="d3">CHEMICAL</data>
    </node>
    <node id="ETHANOL">
      <data key="d0">CHEMICAL</data>
      <data key="d1">Ethanol, a solvent used in the rehydration of tissue sections</data>
      <data key="d2">2f4bf4583547aaf1c5cc6eaea0b058eb</data>
      <data key="d3">CHEMICAL</data>
    </node>
    <node id="CITRATE-PHOSPHATE BUFFER">
      <data key="d0">CHEMICAL</data>
      <data key="d1">Citrate-Phosphate Buffer, a buffer solution used for antigen retrieval in histology</data>
      <data key="d2">2f4bf4583547aaf1c5cc6eaea0b058eb</data>
      <data key="d3">CHEMICAL</data>
    </node>
    <node id="DONKEY SERUM">
      <data key="d0">CHEMICAL</data>
      <data key="d1">Donkey Serum, used as a blocking agent in immunohistochemistry to prevent non-specific binding</data>
      <data key="d2">2f4bf4583547aaf1c5cc6eaea0b058eb</data>
      <data key="d3">CHEMICAL</data>
    </node>
    <node id="ALEXA 488">
      <data key="d0">CHEMICAL</data>
      <data key="d1">Alexa 488 is a fluorescent dye used for labeling antibodies in immunofluorescence studies</data>
      <data key="d2">05fe283d6fa879523f3ab153815ac64b</data>
    </node>
    <node id="ALEXA 647">
      <data key="d0">CHEMICAL</data>
      <data key="d1">Alexa 647 is a fluorescent dye used for labeling antibodies in immunofluorescence studies</data>
      <data key="d2">05fe283d6fa879523f3ab153815ac64b</data>
    </node>
    <node id="DAPI">
      <data key="d0">CHEMICAL</data>
      <data key="d1">DAPI, or 4',6-diamidino-2-phenylindole, is a fluorescent stain that binds strongly to DNA. It is commonly used in fluorescence microscopy to visualize and identify DNA within cells.</data>
      <data key="d2">05fe283d6fa879523f3ab153815ac64b,7a1160d4230f62889d47499ed90adcdd</data>
    </node>
    <node id="RHINITIS">
      <data key="d0">DISEASE</data>
      <data key="d1">Rhinitis is an inflammation of the nasal mucous membrane, often associated with allergic reactions</data>
      <data key="d2">05fe283d6fa879523f3ab153815ac64b</data>
    </node>
    <node id="PERIPHERAL BLOOD MONONUCLEAR CELLS">
      <data key="d0">CELL_LINE</data>
      <data key="d1">Peripheral blood mononuclear cells (PBMCs) are blood cells with a single round nucleus, used in immunological studies</data>
      <data key="d2">05fe283d6fa879523f3ab153815ac64b</data>
    </node>
    <node id="SPEARMAN&#8217;S RHO">
      <data key="d0">BIOLOGICALPATHWAY</data>
      <data key="d1">Spearman&#8217;s rho is a statistical measure of rank correlation, used to assess the relationship between two variables</data>
      <data key="d2">05fe283d6fa879523f3ab153815ac64b</data>
    </node>
    <node id="WILCOXON SIGNED-RANK TEST">
      <data key="d0">BIOLOGICALPATHWAY</data>
      <data key="d1">The Wilcoxon signed-rank test is a non-parametric statistical test used to compare paired data</data>
      <data key="d2">05fe283d6fa879523f3ab153815ac64b</data>
    </node>
    <node id="MANN-WHITNEY RANK SUM TEST">
      <data key="d0">BIOLOGICALPATHWAY</data>
      <data key="d1">The Mann-Whitney rank sum test is a non-parametric test used to compare unpaired data</data>
      <data key="d2">05fe283d6fa879523f3ab153815ac64b</data>
    </node>
    <node id="PRISM 6">
      <data key="d0">CHEMICAL</data>
      <data key="d1">Prism 6 is a software used for statistical analysis and graphing in scientific research</data>
      <data key="d2">05fe283d6fa879523f3ab153815ac64b</data>
    </node>
    <node id="MOUNTING MEDIUM">
      <data key="d0">CHEMICAL</data>
      <data key="d1">Mounting Medium is a substance used to preserve and stabilize samples on microscope slides</data>
      <data key="d2">05fe283d6fa879523f3ab153815ac64b</data>
    </node>
    <node id="EPR8476">
      <data key="d0">PROTEIN</data>
      <data key="d1">EPR8476 is a monoclonal rabbit anti-tryptase antibody used in immunohistochemistry</data>
      <data key="d2">05fe283d6fa879523f3ab153815ac64b</data>
    </node>
    <node id="IGG1">
      <data key="d0">PROTEIN</data>
      <data key="d1">IgG1 is an isotype control antibody used to ensure specificity in immunological assays</data>
      <data key="d2">05fe283d6fa879523f3ab153815ac64b</data>
    </node>
    <node id="T CELLS">
      <data key="d0">CELL_LINE</data>
      <data key="d1">T cells are a type of lymphocyte that play a central role in cell-mediated immunity. They are involved in the immune response and express OX40 in conditions such as atopic dermatitis.</data>
      <data key="d2">2712037f85fc28b3e86b92a719cb7a6c,919f7083e77a7d3378489efeffa0faed</data>
    </node>
    <node id="MONOCYTES">
      <data key="d0">CELL_LINE</data>
      <data key="d1">Monocytes, a type of white blood cell, express high levels of OX40L in atopic dermatitis.</data>
      <data key="d2">7a1160d4230f62889d47499ed90adcdd,919f7083e77a7d3378489efeffa0faed</data>
    </node>
    <node id="ADULTS">
      <data key="d0">CELL_LINE</data>
      <data key="d1">Adults, a group of patients with atopic dermatitis studied for serum sOX40 levels and disease activity</data>
      <data key="d2">919f7083e77a7d3378489efeffa0faed</data>
    </node>
    <node id="CD4+CD45RO+CLA+ T CELLS">
      <data key="d0">CELL_LINE</data>
      <data key="d1">CD4+CD45RO+CLA+ T CELLS are a subset of T cells characterized by the expression of CD4, CD45RO, and cutaneous lymphocyte-associated antigen (CLA). Additionally, these cells express OX40 and are found in higher amounts in patients with atopic dermatitis (AD) compared to healthy controls.</data>
      <data key="d2">7a1160d4230f62889d47499ed90adcdd,919f7083e77a7d3378489efeffa0faed</data>
    </node>
    <node id="CD4+CD45RO+CLA- T CELLS">
      <data key="d0">CELL_LINE</data>
      <data key="d1">A subset of T cells expressing OX40, found in higher amounts in AD patients compared to healthy controls</data>
      <data key="d2">919f7083e77a7d3378489efeffa0faed</data>
    </node>
    <node id="CD8+CD45RO+CLA+ T CELLS">
      <data key="d0">CELL_LINE</data>
      <data key="d1">A subset of T cells expressing OX40, found in lower amounts in AD patients compared to healthy controls</data>
      <data key="d2">919f7083e77a7d3378489efeffa0faed</data>
    </node>
    <node id="CD8+CD45RO+CLA- T CELLS">
      <data key="d0">CELL_LINE</data>
      <data key="d1">A subset of T cells expressing OX40, found in lower amounts in AD patients compared to healthy controls</data>
      <data key="d2">919f7083e77a7d3378489efeffa0faed</data>
    </node>
    <node id="MFI">
      <data key="d0">SYMPTOM</data>
      <data key="d1">MFI, or Median Fluorescence Intensity, is a measure used in flow cytometry to quantify protein expression. Specifically, it is used to measure the amount of OX40 expression per cell.</data>
      <data key="d2">7a1160d4230f62889d47499ed90adcdd,919f7083e77a7d3378489efeffa0faed</data>
    </node>
    <node id="SKIN">
      <data key="d0">CELL_LINE</data>
      <data key="d1">Skin biopsies from AD patients and healthy controls used to study OX40 and OX40L expression</data>
      <data key="d2">919f7083e77a7d3378489efeffa0faed</data>
    </node>
    <node id="CHILDREN">
      <data key="d0" />
      <data key="d1" />
      <data key="d2">919f7083e77a7d3378489efeffa0faed</data>
    </node>
    <node id="EASI">
      <data key="d0">SYMPTOM</data>
      <data key="d1">Eczema Area and Severity Index, a tool used to measure the extent and severity of eczema</data>
      <data key="d2">2712037f85fc28b3e86b92a719cb7a6c,7a1160d4230f62889d47499ed90adcdd</data>
    </node>
    <node id="ELISA">
      <data key="d0">CHEMICAL</data>
      <data key="d1">Enzyme-linked immunoassay, a test used to measure serum levels of proteins</data>
      <data key="d2">7a1160d4230f62889d47499ed90adcdd</data>
    </node>
    <node id="TNF-SUPER FAMILY">
      <data key="d0">PROTEIN</data>
      <data key="d1">Tumor necrosis factor superfamily, a group of proteins involved in inflammation and immune regulation</data>
      <data key="d2">7a1160d4230f62889d47499ed90adcdd</data>
    </node>
    <node id="B CELLS">
      <data key="d0">CELL_LINE</data>
      <data key="d1">A type of white blood cell that can express OX40L and is involved in immune responses</data>
      <data key="d2">7a1160d4230f62889d47499ed90adcdd</data>
    </node>
    <node id="SKIN-HOMING CD4+ T CELLS">
      <data key="d0">CELL_LINE</data>
      <data key="d1">A subset of T cells that migrate to the skin and express OX40 in atopic dermatitis</data>
      <data key="d2">7a1160d4230f62889d47499ed90adcdd</data>
    </node>
    <node id="INFLAMMATORY SITE">
      <data key="d0">BIOLOGICALPATHWAY</data>
      <data key="d1">The location in the body where inflammation occurs, often involving immune cell migration and activation</data>
      <data key="d2">7a1160d4230f62889d47499ed90adcdd</data>
    </node>
    <node id="LOCAL INFLAMMATION">
      <data key="d0">BIOLOGICALPATHWAY</data>
      <data key="d1">The localized immune response in the skin of patients with atopic dermatitis</data>
      <data key="d2">7a1160d4230f62889d47499ed90adcdd</data>
    </node>
    <node id="BIOMARKERS">
      <data key="d0">CHEMICAL</data>
      <data key="d1">Biomarkers are measurable indicators of a biological condition or disease</data>
      <data key="d2">2712037f85fc28b3e86b92a719cb7a6c</data>
      <data key="d3">CHEMICAL</data>
    </node>
    <node id="SKIN THICKNESS">
      <data key="d0">SYMPTOM</data>
      <data key="d1">Skin thickness is a measurable parameter that can indicate inflammation or other skin conditions</data>
      <data key="d2">2712037f85fc28b3e86b92a719cb7a6c</data>
      <data key="d3">SYMPTOM</data>
    </node>
    <node id="INFLAMMATORY REACTION">
      <data key="d0">BIOLOGICALPATHWAY</data>
      <data key="d1">Inflammatory reaction is a biological pathway involving the immune response to infection or injury</data>
      <data key="d2">2712037f85fc28b3e86b92a719cb7a6c</data>
      <data key="d3">BIOLOGICALPATHWAY</data>
    </node>
    <node id="ANTI-OX40 THERAPY">
      <data key="d0">DRUG</data>
      <data key="d1">Anti-OX40 therapy is a treatment targeting the OX40-OX40L interaction to modulate immune responses</data>
      <data key="d2">2712037f85fc28b3e86b92a719cb7a6c</data>
      <data key="d3">DRUG</data>
    </node>
    <node id="ATOPIC CO-MORBIDITIES">
      <data key="d0">DISEASE</data>
      <data key="d1">Atopic co-morbidities are additional atopic conditions that occur alongside a primary atopic disease like AD</data>
      <data key="d2">2712037f85fc28b3e86b92a719cb7a6c</data>
      <data key="d3">DISEASE</data>
    </node>
    <node id="GBR 830">
      <data key="d0">DRUG</data>
      <data key="d1">GBR 830 is an anti-OX40 drug that improves skin gene signatures and clinical scores in patients with atopic dermatitis</data>
      <data key="d2">2712037f85fc28b3e86b92a719cb7a6c</data>
      <data key="d3">DRUG</data>
    </node>
    <node id="BCL-XL">
      <data key="d0">PROTEIN</data>
      <data key="d1">Bcl-xL is a protein that inhibits cell apoptosis and is promoted by OX40</data>
      <data key="d2">2712037f85fc28b3e86b92a719cb7a6c</data>
    </node>
    <node id="BCL-2">
      <data key="d0">PROTEIN</data>
      <data key="d1">Bcl-2 is a protein that regulates cell death by inhibiting apoptosis and is promoted by OX40</data>
      <data key="d2">2712037f85fc28b3e86b92a719cb7a6c</data>
    </node>
    <node id="CD4 T CELLS">
      <data key="d0">CELL_LINE</data>
      <data key="d1">CD4 T cells are a type of immune cell that are essential for initiating and orchestrating the immune response</data>
      <data key="d2">2712037f85fc28b3e86b92a719cb7a6c</data>
    </node>
    <node id="MEMORY CD4 T CELLS">
      <data key="d0">CELL_LINE</data>
      <data key="d1">Memory CD4 T cells are a subset of CD4 T cells that provide long-term immunity by remembering past infections</data>
      <data key="d2">2712037f85fc28b3e86b92a719cb7a6c</data>
    </node>
    <node id="LDL RECEPTOR-DEFICIENT MICE">
      <data key="d0">CELL_LINE</data>
      <data key="d1">LDL receptor-deficient mice are genetically modified mice used to study atherosclerosis and other lipid-related diseases</data>
      <data key="d2">2712037f85fc28b3e86b92a719cb7a6c</data>
    </node>
    <node id="FC EPSILON RI">
      <data key="d0">PROTEIN</data>
      <data key="d1">Fc epsilon RI is a high-affinity receptor for the Fc region of immunoglobulin E (IgE), involved in allergic responses</data>
      <data key="d2">2712037f85fc28b3e86b92a719cb7a6c</data>
    </node>
    <node id="INTERLEUKIN-25">
      <data key="d0">CHEMICAL</data>
      <data key="d1">Interleukin-25 is a cytokine produced by mast cells upon activation and plays a role in the immune response</data>
      <data key="d2">2712037f85fc28b3e86b92a719cb7a6c</data>
    </node>
    <node id="IGG">
      <data key="d0">CHEMICAL</data>
      <data key="d1">Immunoglobulin G, a type of antibody found in blood and extracellular fluid, which controls infection of body tissues</data>
      <data key="d2">2712037f85fc28b3e86b92a719cb7a6c</data>
    </node>
    <node id="SERUM OX40 LIGAND">
      <data key="d0">CHEMICAL</data>
      <data key="d1">Serum OX40 ligand levels can be a potential biomarker of severity and persistence in asthmatic children</data>
      <data key="d2">2712037f85fc28b3e86b92a719cb7a6c</data>
    </node>
    <node id="OX40-OX40L">
      <data key="d0" />
      <data key="d1" />
      <data key="d2">2712037f85fc28b3e86b92a719cb7a6c</data>
    </node>
    <edge source="TNFSF4" target="OX40L">
      <data key="d4">18.0</data>
      <data key="d5">TNFSF4 encodes the protein OX40L</data>
      <data key="d6">87174642d9d24116b8cc01fca23746f2,ab372f2a5df06a33e153fa648bb2b950</data>
    </edge>
    <edge source="TNFSF4" target="SLE">
      <data key="d4">23.0</data>
      <data key="d5">TNFSF4 is identified as a susceptibility gene for systemic lupus erythematosus (SLE) and is associated with the disease.</data>
      <data key="d6">5639a5e5649646c1e4c8deb1e1f0a1b1,87174642d9d24116b8cc01fca23746f2,ab372f2a5df06a33e153fa648bb2b950</data>
    </edge>
    <edge source="TNFSF4" target="SSC">
      <data key="d4">24.0</data>
      <data key="d5">TNFSF4 is associated with susceptibility to systemic sclerosis (SSC). This association indicates that TNFSF4 plays a role in the development and progression of systemic sclerosis, making it a significant factor in understanding the susceptibility to this autoimmune disease.</data>
      <data key="d6">5639a5e5649646c1e4c8deb1e1f0a1b1,87174642d9d24116b8cc01fca23746f2,ab372f2a5df06a33e153fa648bb2b950</data>
    </edge>
    <edge source="TNFSF4" target="AUTOIMMUNE DISEASES">
      <data key="d4">8.0</data>
      <data key="d5">TNFSF4 is associated with susceptibility to multiple autoimmune diseases</data>
      <data key="d6">87174642d9d24116b8cc01fca23746f2</data>
    </edge>
    <edge source="TNFSF4" target="ATHEROSCLEROSIS">
      <data key="d4">7.0</data>
      <data key="d5">Polymorphisms in TNFSF4 have been associated with atherosclerosis</data>
      <data key="d6">87174642d9d24116b8cc01fca23746f2</data>
    </edge>
    <edge source="TNFSF4" target="RS1234314">
      <data key="d4">24.0</data>
      <data key="d5">TNFSF4 and the single nucleotide polymorphism (SNP) rs1234314 are associated with systemic sclerosis and its susceptibility.</data>
      <data key="d6">31513af83d109f0e11eca33fa5fb3204,5db9eda60231516215dcb8b82826f9bc,c89a7a896cf934207d874042e48857da</data>
    </edge>
    <edge source="TNFSF4" target="RS1234315">
      <data key="d4">8.0</data>
      <data key="d5">TNFSF4 and SNP rs1234315 are associated with systemic sclerosis</data>
      <data key="d6">c89a7a896cf934207d874042e48857da</data>
    </edge>
    <edge source="TNFSF4" target="RS2205960">
      <data key="d4">24.0</data>
      <data key="d5">TNFSF4 and the single nucleotide polymorphism (SNP) rs2205960 are associated with systemic sclerosis. Both TNFSF4 and SNP rs2205960 have been identified as contributing factors to the susceptibility of developing systemic sclerosis, indicating their potential role in the pathogenesis of this autoimmune disease.</data>
      <data key="d6">31513af83d109f0e11eca33fa5fb3204,5db9eda60231516215dcb8b82826f9bc,c89a7a896cf934207d874042e48857da</data>
    </edge>
    <edge source="TNFSF4" target="RS844644">
      <data key="d4">23.0</data>
      <data key="d5">TNFSF4 and SNP rs844644 are associated with systemic sclerosis, including its susceptibility. These genetic markers are linked to the development and progression of systemic sclerosis, highlighting their potential role in the disease's pathogenesis.</data>
      <data key="d6">31513af83d109f0e11eca33fa5fb3204,5db9eda60231516215dcb8b82826f9bc,c89a7a896cf934207d874042e48857da</data>
    </edge>
    <edge source="TNFSF4" target="RS12039904">
      <data key="d4">8.0</data>
      <data key="d5">TNFSF4 and SNP rs12039904 are associated with systemic sclerosis</data>
      <data key="d6">c89a7a896cf934207d874042e48857da</data>
    </edge>
    <edge source="TNFSF4" target="RS2795288">
      <data key="d4">8.0</data>
      <data key="d5">TNFSF4 and SNP rs2795288 are associated with systemic sclerosis</data>
      <data key="d6">c89a7a896cf934207d874042e48857da</data>
    </edge>
    <edge source="TNFSF4" target="RS844648">
      <data key="d4">24.0</data>
      <data key="d5">TNFSF4 and the single nucleotide polymorphism (SNP) rs844648 are associated with systemic sclerosis. These genetic markers are linked to the susceptibility of developing systemic sclerosis, indicating a potential role in the pathogenesis of this autoimmune disease.</data>
      <data key="d6">31513af83d109f0e11eca33fa5fb3204,5db9eda60231516215dcb8b82826f9bc,c89a7a896cf934207d874042e48857da</data>
    </edge>
    <edge source="TNFSF4" target="RS844665">
      <data key="d4">21.0</data>
      <data key="d5">TNFSF4 and SNP rs844665 are associated with systemic sclerosis. Despite some conflicting reports, the majority of the literature indicates a significant link between TNFSF4, SNP rs844665, and the development of systemic sclerosis. This association suggests that these genetic factors may play a role in the pathogenesis of the disease, although further research is needed to fully understand the mechanisms involved.</data>
      <data key="d6">31513af83d109f0e11eca33fa5fb3204,5db9eda60231516215dcb8b82826f9bc,c89a7a896cf934207d874042e48857da</data>
    </edge>
    <edge source="TNFSF4" target="RS10912580">
      <data key="d4">8.0</data>
      <data key="d5">TNFSF4 and SNP rs10912580 are associated with systemic sclerosis</data>
      <data key="d6">c89a7a896cf934207d874042e48857da</data>
    </edge>
    <edge source="TNFSF4" target="PUREGENE GENOMIC DNA ISOLATION KIT">
      <data key="d4">7.0</data>
      <data key="d5">PureGene genomic DNA isolation kit is used to extract DNA for genotyping TNFSF4 SNPs</data>
      <data key="d6">c89a7a896cf934207d874042e48857da</data>
    </edge>
    <edge source="TNFSF4" target="ABI TAQMAN SNP GENOTYPING ASSAY">
      <data key="d4">7.0</data>
      <data key="d5">ABI TaqMan SNP genotyping assay is used to genotype TNFSF4 SNPs</data>
      <data key="d6">c89a7a896cf934207d874042e48857da</data>
    </edge>
    <edge source="TNFSF4" target="SAS">
      <data key="d4">7.0</data>
      <data key="d5">SAS software is used for statistical analysis of TNFSF4 SNP data</data>
      <data key="d6">c89a7a896cf934207d874042e48857da</data>
    </edge>
    <edge source="TNFSF4" target="HAPLOVIEW">
      <data key="d4">7.0</data>
      <data key="d5">Haploview is used to analyze linkage disequilibrium of TNFSF4 SNPs</data>
      <data key="d6">c89a7a896cf934207d874042e48857da</data>
    </edge>
    <edge source="TNFSF4" target="CART">
      <data key="d4">15.0</data>
      <data key="d5">TNFSF4 and CART are closely studied in the context of systemic sclerosis (SSc). CART analysis is employed to explore interactions between TNFSF4 single nucleotide polymorphisms (SNPs). Specifically, CART analysis reveals significant interactions between TNFSF4 SNPs in systemic sclerosis, providing insights into the genetic underpinnings of this autoimmune disease.</data>
      <data key="d6">ab372f2a5df06a33e153fa648bb2b950,c89a7a896cf934207d874042e48857da</data>
    </edge>
    <edge source="TNFSF4" target="HAPMAP">
      <data key="d4">7.0</data>
      <data key="d5">HapMap data is used to validate allele calls for TNFSF4 SNPs</data>
      <data key="d6">c89a7a896cf934207d874042e48857da</data>
    </edge>
    <edge source="TNFSF4" target="HARDY&#8211;WEINBERG EQUILIBRIUM">
      <data key="d4">7.0</data>
      <data key="d5">Hardy&#8211;Weinberg equilibrium testing is performed on TNFSF4 SNPs</data>
      <data key="d6">c89a7a896cf934207d874042e48857da</data>
    </edge>
    <edge source="TNFSF4" target="LINKAGE DISEQUILIBRIUM">
      <data key="d4">7.0</data>
      <data key="d5">Linkage disequilibrium is calculated for TNFSF4 SNPs</data>
      <data key="d6">c89a7a896cf934207d874042e48857da</data>
    </edge>
    <edge source="TNFSF4" target="HAPLOTYPE">
      <data key="d4">7.0</data>
      <data key="d5">Haplotype frequency tests are performed on TNFSF4 SNPs</data>
      <data key="d6">c89a7a896cf934207d874042e48857da</data>
    </edge>
    <edge source="TNFSF4" target="RS855648">
      <data key="d4">8.0</data>
      <data key="d5">TNFSF4 and SNP rs855648 are linked to systemic sclerosis</data>
      <data key="d6">5db9eda60231516215dcb8b82826f9bc</data>
    </edge>
    <edge source="TNFSF4" target="NORTH AMERICAN CAUCASIANS">
      <data key="d4">14.0</data>
      <data key="d5">TNFSF4 polymorphisms are associated with SSc in North American CaucasiansTNFSF4 polymorphisms are associated with systemic sclerosis in North American Caucasians</data>
      <data key="d6">ab372f2a5df06a33e153fa648bb2b950</data>
    </edge>
    <edge source="TNFSF4" target="LOGISTIC REGRESSION">
      <data key="d4">14.0</data>
      <data key="d5">Logistic regression is used to estimate the risk of TNFSF4 SNPs in systemic sclerosisLogistic regression is used to estimate the risk of TNFSF4 SNPs in SSc</data>
      <data key="d6">ab372f2a5df06a33e153fa648bb2b950</data>
    </edge>
    <edge source="TNFSF4" target="RA">
      <data key="d4">7.0</data>
      <data key="d5">TNFSF4 is associated with rheumatoid arthritis</data>
      <data key="d6">ab372f2a5df06a33e153fa648bb2b950</data>
    </edge>
    <edge source="TNFSF4" target="TYPE 1A DIABETES">
      <data key="d4">7.0</data>
      <data key="d5">TNFSF4 is associated with type 1A diabetes</data>
      <data key="d6">5639a5e5649646c1e4c8deb1e1f0a1b1</data>
    </edge>
    <edge source="TNFSF4" target="RHEUMATOID ARTHRITIS">
      <data key="d4">7.0</data>
      <data key="d5">TNFSF4 is associated with rheumatoid arthritis</data>
      <data key="d6">5639a5e5649646c1e4c8deb1e1f0a1b1</data>
    </edge>
    <edge source="TNFSF4" target="ATHEROTHROMBOSIS">
      <data key="d4">7.0</data>
      <data key="d5">TNFSF4 is associated with atherothrombosis</data>
      <data key="d6">5639a5e5649646c1e4c8deb1e1f0a1b1</data>
    </edge>
    <edge source="TNFSF4" target="VENOUS THROMBOEMBOLISM">
      <data key="d4">7.0</data>
      <data key="d5">TNFSF4 is associated with venous thromboembolism</data>
      <data key="d6">5639a5e5649646c1e4c8deb1e1f0a1b1</data>
    </edge>
    <edge source="TNFSF4" target="CAROTID ARTERY DISEASE">
      <data key="d4">7.0</data>
      <data key="d5">TNFSF4 is associated with carotid artery disease</data>
      <data key="d6">5639a5e5649646c1e4c8deb1e1f0a1b1</data>
    </edge>
    <edge source="TNFSF4" target="STROKE">
      <data key="d4">7.0</data>
      <data key="d5">TNFSF4 is associated with stroke</data>
      <data key="d6">5639a5e5649646c1e4c8deb1e1f0a1b1</data>
    </edge>
    <edge source="OX40L" target="T CELL">
      <data key="d4">24.0</data>
      <data key="d5">OX40L, also known as OX40 ligand, plays a crucial role in the immune system by enhancing T cell survival. It is expressed on T cells, where it contributes to their longevity and function. This interaction is significant in the context of autoimmune diseases, where the regulation of T cell activity is a key factor in disease progression and management.</data>
      <data key="d6">ab372f2a5df06a33e153fa648bb2b950,f286191a8009d9c0ef61d3de0938f0e6</data>
    </edge>
    <edge source="OX40L" target="B CELL">
      <data key="d4">24.0</data>
      <data key="d5">OX40L, also known as OX40 ligand, plays a significant role in the immune system by enhancing B cell proliferation and differentiation. Additionally, OX40L is expressed on B cells, indicating its direct involvement in B cell-mediated immune responses. This dual role underscores the importance of OX40L in modulating B cell functions and its potential as a target in autoimmune disease research.</data>
      <data key="d6">ab372f2a5df06a33e153fa648bb2b950,f286191a8009d9c0ef61d3de0938f0e6</data>
    </edge>
    <edge source="OX40L" target="NK CELL">
      <data key="d4">16.0</data>
      <data key="d5">OX40L is expressed on natural killer cells</data>
      <data key="d6">ab372f2a5df06a33e153fa648bb2b950</data>
    </edge>
    <edge source="OX40L" target="ENDOTHELIAL CELL">
      <data key="d4">14.0</data>
      <data key="d5">OX40L is expressed on endothelial cells</data>
      <data key="d6">ab372f2a5df06a33e153fa648bb2b950</data>
    </edge>
    <edge source="OX40L" target="SMOOTH MUSCLE CELL">
      <data key="d4">14.0</data>
      <data key="d5">OX40L is expressed on smooth muscle cells</data>
      <data key="d6">ab372f2a5df06a33e153fa648bb2b950</data>
    </edge>
    <edge source="OX40L" target="TH2">
      <data key="d4">14.0</data>
      <data key="d5">OX40L interaction promotes T helper 2 cytokinesOX40L alone induces a Th2 response</data>
      <data key="d6">ab372f2a5df06a33e153fa648bb2b950</data>
    </edge>
    <edge source="OX40L" target="IL-17">
      <data key="d4">22.0</data>
      <data key="d5">OX40L and IL-17 are closely related in the regulation of immune responses. OX40L, a member of the tumor necrosis factor (TNF) superfamily, plays a significant role in modulating the production of interleukin 17 (IL-17), a pro-inflammatory cytokine. Specifically, OX40L interaction has been shown to regulate IL-17 production. However, it is important to note that this regulation can be context-dependent, as some studies suggest that OX40L interaction negatively regulates IL-17 production. This indicates that OX40L may have a complex role in the immune system, potentially acting to both promote and inhibit IL-17 production under different circumstances. Understanding the precise mechanisms and conditions under which OX40L influences IL-17 production is crucial for developing targeted therapies for autoimmune diseases where IL-17 plays a pivotal role.</data>
      <data key="d6">ab372f2a5df06a33e153fa648bb2b950,f286191a8009d9c0ef61d3de0938f0e6</data>
    </edge>
    <edge source="OX40L" target="FOXP3+ REGULATORY T CELL">
      <data key="d4">14.0</data>
      <data key="d5">OX40L interaction inhibits Foxp3+ regulatory T cells</data>
      <data key="d6">ab372f2a5df06a33e153fa648bb2b950</data>
    </edge>
    <edge source="OX40L" target="TYPE I INTERFERON">
      <data key="d4">14.0</data>
      <data key="d5">OX40L and type I interferon together may induce a Th1 response</data>
      <data key="d6">ab372f2a5df06a33e153fa648bb2b950</data>
    </edge>
    <edge source="OX40L" target="DIABETES">
      <data key="d4">14.0</data>
      <data key="d5">Blocking OX40L interactions has shown preventive effects in diabetes</data>
      <data key="d6">ab372f2a5df06a33e153fa648bb2b950</data>
    </edge>
    <edge source="OX40L" target="EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS">
      <data key="d4">14.0</data>
      <data key="d5">Blocking OX40L interactions has shown preventive effects in experimental autoimmune encephalomyelitis</data>
      <data key="d6">ab372f2a5df06a33e153fa648bb2b950</data>
    </edge>
    <edge source="OX40L" target="MULTIPLE SCLEROSIS">
      <data key="d4">14.0</data>
      <data key="d5">Blocking OX40L interactions has shown preventive effects in multiple sclerosis</data>
      <data key="d6">ab372f2a5df06a33e153fa648bb2b950</data>
    </edge>
    <edge source="OX40L" target="C57/BL6">
      <data key="d4">14.0</data>
      <data key="d5">OX40L transgenic mice on the C57/BL6 background develop organ-specific inflammation</data>
      <data key="d6">ab372f2a5df06a33e153fa648bb2b950</data>
    </edge>
    <edge source="OX40L" target="AUTOIMMUNITY">
      <data key="d4">16.0</data>
      <data key="d5">OX40L interactions are involved in the development of autoimmunity</data>
      <data key="d6">ab372f2a5df06a33e153fa648bb2b950</data>
    </edge>
    <edge source="OX40L" target="DENDRITIC CELL">
      <data key="d4">16.0</data>
      <data key="d5">Dendritic cells express OX40L and regulate T helper responses</data>
      <data key="d6">ab372f2a5df06a33e153fa648bb2b950</data>
    </edge>
    <edge source="OX40L" target="MACROPHAGE">
      <data key="d4">2.0</data>
      <data key="d5">Macrophages express OX40L and are involved in immune responses</data>
      <data key="d6">ab372f2a5df06a33e153fa648bb2b950</data>
    </edge>
    <edge source="OX40L" target="TH1">
      <data key="d4">7.0</data>
      <data key="d5">OX40L in combination with type I interferon may induce a Th1 response</data>
      <data key="d6">ab372f2a5df06a33e153fa648bb2b950</data>
    </edge>
    <edge source="OX40L" target="OX40">
      <data key="d4">81.0</data>
      <data key="d5">OX40 and OX40L are co-localized in atopic dermatitis and interact to play a central role in its pathogenesis by generating Th2 memory cells. Their interaction is crucial for T cell activation and survival, as OX40 binds to OX40L to generate a costimulatory signal. This costimulatory signal is essential for T cell activation, survival, and overall costimulation, highlighting the importance of the OX40-OX40L axis in immune responses and the development of atopic dermatitis.</data>
      <data key="d6">05fe283d6fa879523f3ab153815ac64b,2712037f85fc28b3e86b92a719cb7a6c,2f4bf4583547aaf1c5cc6eaea0b058eb,7a1160d4230f62889d47499ed90adcdd,919f7083e77a7d3378489efeffa0faed,a98a120ac25d0f8a533fcdcd479913b1,f286191a8009d9c0ef61d3de0938f0e6</data>
    </edge>
    <edge source="OX40L" target="ANTI-OX40 LIGAND MONOCLONAL ANTIBODY">
      <data key="d4">8.0</data>
      <data key="d5">Anti-OX40 ligand monoclonal antibody targets OX40/OX40L interactions</data>
      <data key="d6">f286191a8009d9c0ef61d3de0938f0e6</data>
    </edge>
    <edge source="OX40L" target="TH-2 CELLS">
      <data key="d4">8.0</data>
      <data key="d5">OX40L is critical for the development of pathogenic Th-2 cells</data>
      <data key="d6">f286191a8009d9c0ef61d3de0938f0e6</data>
    </edge>
    <edge source="OX40L" target="FOX P3+ REGULATORY T-CELLS">
      <data key="d4">7.0</data>
      <data key="d5">OX40L affects the induction of Foxp3+ regulatory T-cells</data>
      <data key="d6">f286191a8009d9c0ef61d3de0938f0e6</data>
    </edge>
    <edge source="OX40L" target="TYPE I IFNS">
      <data key="d4">7.0</data>
      <data key="d5">OX40L and type I IFNs regulate Th cell responses</data>
      <data key="d6">f286191a8009d9c0ef61d3de0938f0e6</data>
    </edge>
    <edge source="OX40L" target="MEMORY T-CELLS">
      <data key="d4">7.0</data>
      <data key="d5">OX40L expands memory T-cells</data>
      <data key="d6">f286191a8009d9c0ef61d3de0938f0e6</data>
    </edge>
    <edge source="OX40L" target="ALLOANTIBODY">
      <data key="d4">8.0</data>
      <data key="d5">OX40L on B cells is essential for persistent alloantibody production</data>
      <data key="d6">f286191a8009d9c0ef61d3de0938f0e6</data>
    </edge>
    <edge source="OX40L" target="PLASMACYTOID DENDRITIC CELLS">
      <data key="d4">7.0</data>
      <data key="d5">OX40L on plasmacytoid dendritic cells regulates Th cell responses</data>
      <data key="d6">f286191a8009d9c0ef61d3de0938f0e6</data>
    </edge>
    <edge source="OX40L" target="TH CELL">
      <data key="d4">7.0</data>
      <data key="d5">OX40L is involved in the regulation of Th cell responses</data>
      <data key="d6">f286191a8009d9c0ef61d3de0938f0e6</data>
    </edge>
    <edge source="OX40L" target="OX40/OX40L INTERACTION">
      <data key="d4">9.0</data>
      <data key="d5">OX40L is part of the OX40/OX40L interaction</data>
      <data key="d6">f286191a8009d9c0ef61d3de0938f0e6</data>
    </edge>
    <edge source="OX40L" target="TH-2 PRIMING">
      <data key="d4">8.0</data>
      <data key="d5">OX40L acts as a costimulatory signal for Th-2 priming</data>
      <data key="d6">f286191a8009d9c0ef61d3de0938f0e6</data>
    </edge>
    <edge source="OX40L" target="MEMORY INDUCTION">
      <data key="d4">8.0</data>
      <data key="d5">OX40L is involved in memory induction</data>
      <data key="d6">f286191a8009d9c0ef61d3de0938f0e6</data>
    </edge>
    <edge source="OX40L" target="PATHOGENIC TH-2 CELLS">
      <data key="d4">8.0</data>
      <data key="d5">OX40L is critical for the development of pathogenic Th-2 cells</data>
      <data key="d6">f286191a8009d9c0ef61d3de0938f0e6</data>
    </edge>
    <edge source="OX40L" target="ATOPIC DERMATITIS">
      <data key="d4">9.0</data>
      <data key="d5">OX40L is crucial for the generation of Th2 memory cells, which are central to the pathogenesis of atopic dermatitis</data>
      <data key="d6">a98a120ac25d0f8a533fcdcd479913b1</data>
    </edge>
    <edge source="OX40L" target="ALEXA 488">
      <data key="d4">7.0</data>
      <data key="d5">Alexa 488 is used to label antibodies against OX40L</data>
      <data key="d6">05fe283d6fa879523f3ab153815ac64b</data>
    </edge>
    <edge source="OX40L" target="IGG1">
      <data key="d4">6.0</data>
      <data key="d5">IgG1 is used as an isotype control in assays involving OX40L</data>
      <data key="d6">05fe283d6fa879523f3ab153815ac64b</data>
    </edge>
    <edge source="OX40L" target="AD">
      <data key="d4">24.0</data>
      <data key="d5">OX40L is co-localized with OX40 in the skin of patients with atopic dermatitis (AD). It is highly expressed by monocytes in atopic dermatitis, indicating its significant role in the disease's pathophysiology. Additionally, OX40L levels are measured in patients with atopic dermatitis, further underscoring its importance as a biomarker and potential therapeutic target in managing this autoimmune condition.</data>
      <data key="d6">05fe283d6fa879523f3ab153815ac64b,2712037f85fc28b3e86b92a719cb7a6c,919f7083e77a7d3378489efeffa0faed</data>
    </edge>
    <edge source="OX40L" target="MONOCYTES">
      <data key="d4">14.0</data>
      <data key="d5">OX40L is expressed primarily by monocytes in atopic dermatitis (AD). It is highly expressed by these monocytes, indicating a significant role in the pathophysiology of AD.</data>
      <data key="d6">7a1160d4230f62889d47499ed90adcdd,919f7083e77a7d3378489efeffa0faed</data>
    </edge>
    <edge source="OX40L" target="PBMCS">
      <data key="d4">6.0</data>
      <data key="d5">OX40L expression is studied in PBMCs from AD patients</data>
      <data key="d6">919f7083e77a7d3378489efeffa0faed</data>
    </edge>
    <edge source="OX40L" target="HC">
      <data key="d4">6.0</data>
      <data key="d5">OX40L expression is compared between AD patients and healthy controls</data>
      <data key="d6">919f7083e77a7d3378489efeffa0faed</data>
    </edge>
    <edge source="OX40L" target="SKIN">
      <data key="d4">8.0</data>
      <data key="d5">OX40L and OX40 are co-localized in the skin of AD patients</data>
      <data key="d6">919f7083e77a7d3378489efeffa0faed</data>
    </edge>
    <edge source="OX40L" target="MAST CELLS">
      <data key="d4">15.0</data>
      <data key="d5">OX40L is expressed by mast cells in the skin of atopic dermatitis (AD) patients. OX40L-expressing cells in the dermis have been confirmed to be mast cells.</data>
      <data key="d6">7a1160d4230f62889d47499ed90adcdd,919f7083e77a7d3378489efeffa0faed</data>
    </edge>
    <edge source="OX40L" target="IGE">
      <data key="d4">7.0</data>
      <data key="d5">Increased expression of OX40L on B cells is associated with the level of total IgE in allergic asthma patients</data>
      <data key="d6">7a1160d4230f62889d47499ed90adcdd</data>
    </edge>
    <edge source="OX40L" target="TRYPTASE">
      <data key="d4">8.0</data>
      <data key="d5">OX40L-expressing cells are confirmed to be mast cells by positive tryptase staining</data>
      <data key="d6">7a1160d4230f62889d47499ed90adcdd</data>
    </edge>
    <edge source="OX40L" target="MFI">
      <data key="d4">6.0</data>
      <data key="d5">Median fluorescence intensity of OX40L showed no difference between patients with atopic dermatitis and healthy controls</data>
      <data key="d6">7a1160d4230f62889d47499ed90adcdd</data>
    </edge>
    <edge source="OX40L" target="DAPI">
      <data key="d4">6.0</data>
      <data key="d5">Nuclear staining was carried out by DAPI to identify OX40L-positive cells</data>
      <data key="d6">7a1160d4230f62889d47499ed90adcdd</data>
    </edge>
    <edge source="OX40L" target="B CELLS">
      <data key="d4">7.0</data>
      <data key="d5">Increased expression of OX40L on B cells is associated with allergic asthma</data>
      <data key="d6">7a1160d4230f62889d47499ed90adcdd</data>
    </edge>
    <edge source="OX40L" target="TH2 CELLS">
      <data key="d4">8.0</data>
      <data key="d5">OX40L is crucial for the development of pathogenic Th2 cells</data>
      <data key="d6">2712037f85fc28b3e86b92a719cb7a6c</data>
    </edge>
    <edge source="OX40L" target="RHEUMATOID ARTHRITIS">
      <data key="d4">7.0</data>
      <data key="d5">Soluble OX40L is associated with the presence of autoantibodies in early rheumatoid arthritis</data>
      <data key="d6">2712037f85fc28b3e86b92a719cb7a6c</data>
    </edge>
    <edge source="OX40L" target="ASTHMA">
      <data key="d4">7.0</data>
      <data key="d5">OX40L is an important inflammatory mediator in adult bronchial asthma</data>
      <data key="d6">2712037f85fc28b3e86b92a719cb7a6c</data>
    </edge>
    <edge source="SLE" target="PTPN22">
      <data key="d4">7.0</data>
      <data key="d5">PTPN22 is associated with the development of systemic lupus erythematosus</data>
      <data key="d6">87174642d9d24116b8cc01fca23746f2</data>
    </edge>
    <edge source="SLE" target="STAT4">
      <data key="d4">14.0</data>
      <data key="d5">STAT4 is a susceptibility gene that influences the genetic predisposition to systemic lupus erythematosus (SLE).</data>
      <data key="d6">5639a5e5649646c1e4c8deb1e1f0a1b1,87174642d9d24116b8cc01fca23746f2</data>
    </edge>
    <edge source="SLE" target="IRF5">
      <data key="d4">14.0</data>
      <data key="d5">IRF5 is a gene that plays a significant role in systemic lupus erythematosus (SLE), an autoimmune disease. Research indicates that IRF5 is associated with polymorphisms linked to SLE, suggesting that variations in this gene can influence the susceptibility to the disease. Furthermore, IRF5 defines risk and protective haplotypes for human lupus, highlighting its critical role in determining the genetic predisposition to SLE.</data>
      <data key="d6">5639a5e5649646c1e4c8deb1e1f0a1b1,87174642d9d24116b8cc01fca23746f2</data>
    </edge>
    <edge source="SLE" target="FAS">
      <data key="d4">8.0</data>
      <data key="d5">Systemic lupus erythematosus (SLE) is associated with polymorphisms in the FAS gene. Specifically, polymorphisms in the promoter region of the FAS gene influence susceptibility to SLE. These genetic variations in FAS are linked to the development and progression of this autoimmune disease.</data>
      <data key="d6">5639a5e5649646c1e4c8deb1e1f0a1b1,87174642d9d24116b8cc01fca23746f2</data>
    </edge>
    <edge source="SLE" target="INTERFERON REGULATORY FACTOR 5">
      <data key="d4">7.0</data>
      <data key="d5">IRF5 is associated with polymorphisms linked to systemic lupus erythematosus</data>
      <data key="d6">87174642d9d24116b8cc01fca23746f2</data>
    </edge>
    <edge source="SLE" target="TYPE I INTERFERON">
      <data key="d4">7.0</data>
      <data key="d5">Type I interferon pathway is upregulated in patients with systemic lupus erythematosus</data>
      <data key="d6">87174642d9d24116b8cc01fca23746f2</data>
    </edge>
    <edge source="SLE" target="ANTIBODIES">
      <data key="d4">8.0</data>
      <data key="d5">Patients with systemic lupus erythematosus have a myriad of circulating antinuclear antibodies</data>
      <data key="d6">87174642d9d24116b8cc01fca23746f2</data>
    </edge>
    <edge source="SLE" target="SSC">
      <data key="d4">6.0</data>
      <data key="d5">Patients with systemic sclerosis were excluded if they met criteria for systemic lupus erythematosus</data>
      <data key="d6">c89a7a896cf934207d874042e48857da</data>
    </edge>
    <edge source="SLE" target="BANK1">
      <data key="d4">7.0</data>
      <data key="d5">BANK1 is associated with systemic lupus erythematosus</data>
      <data key="d6">5639a5e5649646c1e4c8deb1e1f0a1b1</data>
    </edge>
    <edge source="SLE" target="ANTI-RNP ANTIBODIES">
      <data key="d4">7.0</data>
      <data key="d5">Anti-RNP antibodies are associated with systemic lupus erythematosus</data>
      <data key="d6">5639a5e5649646c1e4c8deb1e1f0a1b1</data>
    </edge>
    <edge source="SLE" target="INTERFERON">
      <data key="d4">7.0</data>
      <data key="d5">Interferon is involved in immune response in systemic lupus erythematosus</data>
      <data key="d6">5639a5e5649646c1e4c8deb1e1f0a1b1</data>
    </edge>
    <edge source="SLE" target="IRF5 RS2004640">
      <data key="d4">7.0</data>
      <data key="d5">IRF5 rs2004640 is associated with systemic lupus erythematosus</data>
      <data key="d6">5639a5e5649646c1e4c8deb1e1f0a1b1</data>
    </edge>
    <edge source="SSC" target="RS1234314">
      <data key="d4">45.0</data>
      <data key="d5">SNP rs1234314 is associated with susceptibility to systemic sclerosis (SSC). This single nucleotide polymorphism (SNP) has been identified as a genetic factor that may influence an individual's likelihood of developing systemic sclerosis, a chronic autoimmune disease characterized by fibrosis of the skin and internal organs. The association between rs1234314 and SSC highlights the importance of genetic factors in the pathogenesis of this complex disease.</data>
      <data key="d6">31513af83d109f0e11eca33fa5fb3204,5db9eda60231516215dcb8b82826f9bc,87174642d9d24116b8cc01fca23746f2,e2d4a3467d27e6de3b2eea8b20f310e8</data>
    </edge>
    <edge source="SSC" target="RS2205960">
      <data key="d4">52.0</data>
      <data key="d5">SNP rs2205960 is associated with susceptibility to systemic sclerosis (SSC). This single nucleotide polymorphism (SNP) has been identified as a genetic factor that may influence an individual's likelihood of developing systemic sclerosis, a chronic autoimmune disease characterized by fibrosis of the skin and internal organs. The association between rs2205960 and SSC highlights the potential genetic underpinnings of the disease, providing a target for further research into its pathogenesis and potential therapeutic interventions.</data>
      <data key="d6">31513af83d109f0e11eca33fa5fb3204,5639a5e5649646c1e4c8deb1e1f0a1b1,5db9eda60231516215dcb8b82826f9bc,87174642d9d24116b8cc01fca23746f2,ab372f2a5df06a33e153fa648bb2b950,e2d4a3467d27e6de3b2eea8b20f310e8</data>
    </edge>
    <edge source="SSC" target="RS844648">
      <data key="d4">45.0</data>
      <data key="d5">SNP rs844648 is associated with susceptibility to systemic sclerosis (SSC). This single nucleotide polymorphism (SNP) has been identified as a genetic factor that may influence an individual's likelihood of developing systemic sclerosis, a chronic autoimmune disease characterized by fibrosis of the skin and internal organs. The association between rs844648 and SSC highlights the potential role of genetic predisposition in the pathogenesis of this complex condition.</data>
      <data key="d6">31513af83d109f0e11eca33fa5fb3204,5db9eda60231516215dcb8b82826f9bc,87174642d9d24116b8cc01fca23746f2,e2d4a3467d27e6de3b2eea8b20f310e8</data>
    </edge>
    <edge source="SSC" target="RS844644">
      <data key="d4">43.0</data>
      <data key="d5">SNP rs844644 is associated with systemic sclerosis (SSC) and systemic sclerosis susceptibility. Additionally, SNP rs844644 has been identified as having a protective effect against systemic sclerosis.</data>
      <data key="d6">31513af83d109f0e11eca33fa5fb3204,5db9eda60231516215dcb8b82826f9bc,87174642d9d24116b8cc01fca23746f2,e2d4a3467d27e6de3b2eea8b20f310e8</data>
    </edge>
    <edge source="SSC" target="IRF5">
      <data key="d4">14.0</data>
      <data key="d5">IRF5 is a gene associated with systemic sclerosis (SSC) susceptibility. It is linked to polymorphisms that are connected to the development of systemic sclerosis, indicating its significant role in the genetic predisposition to this autoimmune disease.</data>
      <data key="d6">87174642d9d24116b8cc01fca23746f2,ab372f2a5df06a33e153fa648bb2b950</data>
    </edge>
    <edge source="SSC" target="FAS">
      <data key="d4">15.0</data>
      <data key="d5">FAS is a gene associated with systemic sclerosis (SSC) susceptibility. It is linked to polymorphisms that influence the likelihood of developing systemic sclerosis. Specifically, polymorphisms in the promoter region of the FAS gene have been identified as factors that affect susceptibility to this autoimmune disease.</data>
      <data key="d6">5639a5e5649646c1e4c8deb1e1f0a1b1,87174642d9d24116b8cc01fca23746f2,ab372f2a5df06a33e153fa648bb2b950</data>
    </edge>
    <edge source="SSC" target="MYOSITIS">
      <data key="d4">13.0</data>
      <data key="d5">Systemic sclerosis (SSC) and myositis are interconnected conditions. Myositis can be a symptom in patients with systemic sclerosis, indicating that muscle inflammation is a possible manifestation of this autoimmune disease. Conversely, patients with systemic sclerosis may also exhibit symptoms of myositis, further highlighting the overlap between these two conditions. This relationship underscores the complexity of autoimmune diseases, where multiple symptoms and conditions can coexist and influence each other.</data>
      <data key="d6">87174642d9d24116b8cc01fca23746f2,c89a7a896cf934207d874042e48857da</data>
    </edge>
    <edge source="SSC" target="SJOGREN'S SYNDROME">
      <data key="d4">13.0</data>
      <data key="d5">Systemic sclerosis (SSC) is a complex autoimmune disease that can present with a variety of symptoms and comorbid conditions. Notably, patients with systemic sclerosis may also have Sjogren's syndrome or exhibit symptoms characteristic of Sjogren's syndrome. This overlap suggests a potential interrelationship between the two conditions, highlighting the need for comprehensive diagnostic and therapeutic approaches to manage patients who may be affected by both SSC and Sjogren's syndrome.</data>
      <data key="d6">87174642d9d24116b8cc01fca23746f2,c89a7a896cf934207d874042e48857da</data>
    </edge>
    <edge source="SSC" target="INTERFERON REGULATORY FACTOR 5">
      <data key="d4">7.0</data>
      <data key="d5">IRF5 is associated with polymorphisms linked to systemic sclerosis</data>
      <data key="d6">87174642d9d24116b8cc01fca23746f2</data>
    </edge>
    <edge source="SSC" target="TYPE I INTERFERON">
      <data key="d4">7.0</data>
      <data key="d5">Type I interferon pathway is upregulated in patients with systemic sclerosis</data>
      <data key="d6">87174642d9d24116b8cc01fca23746f2</data>
    </edge>
    <edge source="SSC" target="ANTIBODIES">
      <data key="d4">8.0</data>
      <data key="d5">Patients with systemic sclerosis have a myriad of circulating antinuclear antibodies</data>
      <data key="d6">87174642d9d24116b8cc01fca23746f2</data>
    </edge>
    <edge source="SSC" target="EXTRACELLULAR MATRIX">
      <data key="d4">8.0</data>
      <data key="d5">Excessive extracellular matrix deposition is a cardinal feature of systemic sclerosis</data>
      <data key="d6">87174642d9d24116b8cc01fca23746f2</data>
    </edge>
    <edge source="SSC" target="INFLAMMATION">
      <data key="d4">8.0</data>
      <data key="d5">Inflammation is a cardinal feature of systemic sclerosis</data>
      <data key="d6">87174642d9d24116b8cc01fca23746f2</data>
    </edge>
    <edge source="SSC" target="VASCULOPATHY">
      <data key="d4">8.0</data>
      <data key="d5">Vasculopathy is a cardinal feature of systemic sclerosis</data>
      <data key="d6">87174642d9d24116b8cc01fca23746f2</data>
    </edge>
    <edge source="SSC" target="FIBROSIS">
      <data key="d4">1.0</data>
      <data key="d5">Fibrosis is a hallmark of systemic sclerosis</data>
      <data key="d6">87174642d9d24116b8cc01fca23746f2</data>
    </edge>
    <edge source="SSC" target="CREST">
      <data key="d4">8.0</data>
      <data key="d5">CREST features are used in the classification of systemic sclerosis</data>
      <data key="d6">c89a7a896cf934207d874042e48857da</data>
    </edge>
    <edge source="SSC" target="LOGISTIC REGRESSION">
      <data key="d4">7.0</data>
      <data key="d5">Logistic regression analysis is used to confirm associations with systemic sclerosis</data>
      <data key="d6">c89a7a896cf934207d874042e48857da</data>
    </edge>
    <edge source="SSC" target="RS844665">
      <data key="d4">35.0</data>
      <data key="d5">SNP rs844665 is associated with systemic sclerosis and systemic sclerosis susceptibility. However, some studies indicate that SNP rs844665 is not significantly associated with systemic sclerosis. This suggests that while there may be a potential link between rs844665 and systemic sclerosis, the association is not consistently observed across all research, indicating the need for further investigation to clarify its role in the disease.</data>
      <data key="d6">31513af83d109f0e11eca33fa5fb3204,5db9eda60231516215dcb8b82826f9bc,e2d4a3467d27e6de3b2eea8b20f310e8</data>
    </edge>
    <edge source="SSC" target="LSSC">
      <data key="d4">25.0</data>
      <data key="d5">Limited systemic sclerosis is a subset of systemic sclerosis</data>
      <data key="d6">31513af83d109f0e11eca33fa5fb3204,ab372f2a5df06a33e153fa648bb2b950</data>
    </edge>
    <edge source="SSC" target="DSSC">
      <data key="d4">25.0</data>
      <data key="d5">Diffuse systemic sclerosis is a subset of systemic sclerosis</data>
      <data key="d6">31513af83d109f0e11eca33fa5fb3204,ab372f2a5df06a33e153fa648bb2b950</data>
    </edge>
    <edge source="SSC" target="ACA">
      <data key="d4">8.0</data>
      <data key="d5">Anti-centromere antibodies are associated with a subset of systemic sclerosis</data>
      <data key="d6">31513af83d109f0e11eca33fa5fb3204</data>
    </edge>
    <edge source="SSC" target="ATA">
      <data key="d4">8.0</data>
      <data key="d5">Anti-topoisomerase antibodies are associated with a subset of systemic sclerosis</data>
      <data key="d6">31513af83d109f0e11eca33fa5fb3204</data>
    </edge>
    <edge source="SSC" target="ARA">
      <data key="d4">8.0</data>
      <data key="d5">Anti-RNA polymerase III antibodies are associated with a subset of systemic sclerosis</data>
      <data key="d6">31513af83d109f0e11eca33fa5fb3204</data>
    </edge>
    <edge source="SSC" target="C-G-A-A-C">
      <data key="d4">8.0</data>
      <data key="d5">The C-G-A-A-C haplotype is associated with systemic sclerosis risk</data>
      <data key="d6">31513af83d109f0e11eca33fa5fb3204</data>
    </edge>
    <edge source="SSC" target="G-G-C-G-C">
      <data key="d4">8.0</data>
      <data key="d5">The G-G-C-G-C haplotype is associated with systemic sclerosis risk</data>
      <data key="d6">31513af83d109f0e11eca33fa5fb3204</data>
    </edge>
    <edge source="SSC" target="G-G-C-G-T">
      <data key="d4">8.0</data>
      <data key="d5">The G-G-C-G-T haplotype is associated with systemic sclerosis risk</data>
      <data key="d6">31513af83d109f0e11eca33fa5fb3204</data>
    </edge>
    <edge source="SSC" target="G-T-C-G-C">
      <data key="d4">8.0</data>
      <data key="d5">The G-T-C-G-C haplotype is associated with systemic sclerosis risk</data>
      <data key="d6">31513af83d109f0e11eca33fa5fb3204</data>
    </edge>
    <edge source="SSC" target="C-G-A-G-C">
      <data key="d4">8.0</data>
      <data key="d5">The C-G-A-G-C haplotype is protective against systemic sclerosis</data>
      <data key="d6">31513af83d109f0e11eca33fa5fb3204</data>
    </edge>
    <edge source="SSC" target="RS855648">
      <data key="d4">14.0</data>
      <data key="d5">SNP rs855648 is associated with systemic sclerosis (SSC) and is linked to an increased susceptibility to this autoimmune disease.</data>
      <data key="d6">5db9eda60231516215dcb8b82826f9bc,ab372f2a5df06a33e153fa648bb2b950</data>
    </edge>
    <edge source="SSC" target="ANTI-CENTROMERE">
      <data key="d4">32.0</data>
      <data key="d5">Anti-centromere antibodies are associated with systemic sclerosis</data>
      <data key="d6">5db9eda60231516215dcb8b82826f9bc,e2d4a3467d27e6de3b2eea8b20f310e8</data>
    </edge>
    <edge source="SSC" target="ANTI-TOPOISOMERASE I">
      <data key="d4">39.0</data>
      <data key="d5">Anti-topoisomerase I antibodies, also known as anti-topoisomerase I, are autoantibodies that are associated with systemic sclerosis (SSC). These antibodies are significant markers in the diagnosis and understanding of systemic sclerosis, a chronic autoimmune disease characterized by fibrosis, vascular alterations, and autoantibodies.</data>
      <data key="d6">5db9eda60231516215dcb8b82826f9bc,ab372f2a5df06a33e153fa648bb2b950,e2d4a3467d27e6de3b2eea8b20f310e8</data>
    </edge>
    <edge source="SSC" target="ANTI-RNA POLYMERASE III">
      <data key="d4">11.0</data>
      <data key="d5">Anti-RNA polymerase III antibodies, also known as anti-RNA polymerase III, are autoantibodies associated with systemic sclerosis (SSC). These antibodies are significant markers in the diagnosis and understanding of systemic sclerosis, a chronic autoimmune disease characterized by fibrosis, vascular alterations, and autoantibodies.</data>
      <data key="d6">5db9eda60231516215dcb8b82826f9bc,ab372f2a5df06a33e153fa648bb2b950,e2d4a3467d27e6de3b2eea8b20f310e8</data>
    </edge>
    <edge source="SSC" target="RS944648">
      <data key="d4">14.0</data>
      <data key="d5">SNP rs944648 is associated with systemic sclerosis</data>
      <data key="d6">5639a5e5649646c1e4c8deb1e1f0a1b1,ab372f2a5df06a33e153fa648bb2b950</data>
    </edge>
    <edge source="SSC" target="AUTOANTIBODY">
      <data key="d4">14.0</data>
      <data key="d5">Autoantibodies are associated with systemic sclerosis and its subsetsAutoantibodies are associated with systemic sclerosis</data>
      <data key="d6">ab372f2a5df06a33e153fa648bb2b950</data>
    </edge>
    <edge source="SSC" target="BENJAMINI AND HOCHBERG FALSE DISCOVERY RATE METHOD">
      <data key="d4">7.0</data>
      <data key="d5">Benjamini and Hochberg false discovery rate method is used to correct p values in SSc studies</data>
      <data key="d6">ab372f2a5df06a33e153fa648bb2b950</data>
    </edge>
    <edge source="SSC" target="&#935;2">
      <data key="d4">7.0</data>
      <data key="d5">Chi-squared test is used to calculate raw p values in SSc studies</data>
      <data key="d6">ab372f2a5df06a33e153fa648bb2b950</data>
    </edge>
    <edge source="SSC" target="D&#8217;">
      <data key="d4">7.0</data>
      <data key="d5">Disequilibrium coefficient D&#8217; is used to measure linkage disequilibrium between SNPs in SSc</data>
      <data key="d6">ab372f2a5df06a33e153fa648bb2b950</data>
    </edge>
    <edge source="SSC" target="R">
      <data key="d4">14.0</data>
      <data key="d5">Measure of strength of linkage disequilibrium between SNPs in SScr values measure the strength of linkage disequilibrium between SNPs in systemic sclerosis</data>
      <data key="d6">ab372f2a5df06a33e153fa648bb2b950</data>
    </edge>
    <edge source="SSC" target="HAPLOTYPE BLOCK">
      <data key="d4">14.0</data>
      <data key="d5">Haplotype block structure is studied in relation to SScHaplotype block structure is studied in relation to systemic sclerosis</data>
      <data key="d6">ab372f2a5df06a33e153fa648bb2b950</data>
    </edge>
    <edge source="SSC" target="LINKAGE DISEQUILIBRIUM">
      <data key="d4">7.0</data>
      <data key="d5">Linkage disequilibrium is studied in relation to SSc</data>
      <data key="d6">ab372f2a5df06a33e153fa648bb2b950</data>
    </edge>
    <edge source="SSC" target="GENDER">
      <data key="d4">7.0</data>
      <data key="d5">Gender is controlled for in logistic regression analysis of TNFSF4 SNPs in SSc</data>
      <data key="d6">ab372f2a5df06a33e153fa648bb2b950</data>
    </edge>
    <edge source="SSC" target="PFDR">
      <data key="d4">7.0</data>
      <data key="d5">pFDR refers to corrected p values using the Benjamini and Hochberg false discovery rate method in systemic sclerosis studies</data>
      <data key="d6">ab372f2a5df06a33e153fa648bb2b950</data>
    </edge>
    <edge source="SSC" target="PU">
      <data key="d4">7.0</data>
      <data key="d5">pU refers to raw chi-squared p values in systemic sclerosis studies</data>
      <data key="d6">ab372f2a5df06a33e153fa648bb2b950</data>
    </edge>
    <edge source="SSC" target="LD">
      <data key="d4">7.0</data>
      <data key="d5">Linkage disequilibrium is studied in relation to systemic sclerosis</data>
      <data key="d6">ab372f2a5df06a33e153fa648bb2b950</data>
    </edge>
    <edge source="SSC" target="D'">
      <data key="d4">7.0</data>
      <data key="d5">Disequilibrium coefficient D' measures the strength of linkage disequilibrium between SNPs in systemic sclerosis</data>
      <data key="d6">ab372f2a5df06a33e153fa648bb2b950</data>
    </edge>
    <edge source="SSC" target="MHC CLASS II">
      <data key="d4">7.0</data>
      <data key="d5">MHC class II is a gene associated with systemic sclerosis susceptibility</data>
      <data key="d6">ab372f2a5df06a33e153fa648bb2b950</data>
    </edge>
    <edge source="SSC" target="PTPN22">
      <data key="d4">7.0</data>
      <data key="d5">PTPN22 is a gene associated with systemic sclerosis susceptibility</data>
      <data key="d6">ab372f2a5df06a33e153fa648bb2b950</data>
    </edge>
    <edge source="SSC" target="AIF1">
      <data key="d4">7.0</data>
      <data key="d5">AIF1 is a gene associated with systemic sclerosis susceptibility</data>
      <data key="d6">ab372f2a5df06a33e153fa648bb2b950</data>
    </edge>
    <edge source="SSC" target="STAT4">
      <data key="d4">14.0</data>
      <data key="d5">STAT4 is a gene that influences the genetic predisposition to systemic sclerosis (SSC). It is associated with the susceptibility to developing systemic sclerosis, indicating its significant role in the pathogenesis of this autoimmune disease.</data>
      <data key="d6">5639a5e5649646c1e4c8deb1e1f0a1b1,ab372f2a5df06a33e153fa648bb2b950</data>
    </edge>
    <edge source="SSC" target="CREST SYNDROME">
      <data key="d4">8.0</data>
      <data key="d5">CREST syndrome is a subset of systemic sclerosis</data>
      <data key="d6">5639a5e5649646c1e4c8deb1e1f0a1b1</data>
    </edge>
    <edge source="SSC" target="ANTI-CENTROMERE ANTIBODIES">
      <data key="d4">7.0</data>
      <data key="d5">Anti-centromere antibodies are associated with systemic sclerosis</data>
      <data key="d6">5639a5e5649646c1e4c8deb1e1f0a1b1</data>
    </edge>
    <edge source="SSC" target="ANTI-TOPOISOMERASE I ANTIBODIES">
      <data key="d4">7.0</data>
      <data key="d5">Anti-topoisomerase I antibodies are associated with systemic sclerosis</data>
      <data key="d6">5639a5e5649646c1e4c8deb1e1f0a1b1</data>
    </edge>
    <edge source="SSC" target="FIBRILLARIN">
      <data key="d4">7.0</data>
      <data key="d5">Fibrillarin is targeted by autoantibodies in systemic sclerosis</data>
      <data key="d6">5639a5e5649646c1e4c8deb1e1f0a1b1</data>
    </edge>
    <edge source="SSC" target="IRF5 RS2004640">
      <data key="d4">7.0</data>
      <data key="d5">IRF5 rs2004640 is associated with systemic sclerosis</data>
      <data key="d6">5639a5e5649646c1e4c8deb1e1f0a1b1</data>
    </edge>
    <edge source="SSC" target="FAS -670G&gt;A">
      <data key="d4">1.0</data>
      <data key="d5">FAS -670G&gt;A polymorphism influences susceptibility to systemic sclerosis</data>
      <data key="d6">5639a5e5649646c1e4c8deb1e1f0a1b1</data>
    </edge>
    <edge source="RS1234314" target="LSSC">
      <data key="d4">7.0</data>
      <data key="d5">SNP rs1234314 is more common in limited systemic sclerosis compared to controls</data>
      <data key="d6">31513af83d109f0e11eca33fa5fb3204</data>
    </edge>
    <edge source="RS1234314" target="DSSC">
      <data key="d4">7.0</data>
      <data key="d5">SNP rs1234314 is more common in diffuse systemic sclerosis compared to controls</data>
      <data key="d6">31513af83d109f0e11eca33fa5fb3204</data>
    </edge>
    <edge source="RS1234314" target="ACA">
      <data key="d4">14.0</data>
      <data key="d5">SNP rs1234314 is associated with ACA-positive systemic sclerosis</data>
      <data key="d6">31513af83d109f0e11eca33fa5fb3204</data>
    </edge>
    <edge source="RS1234314" target="ATA">
      <data key="d4">14.0</data>
      <data key="d5">SNP rs1234314 is associated with ATA-positive systemic sclerosis</data>
      <data key="d6">31513af83d109f0e11eca33fa5fb3204</data>
    </edge>
    <edge source="RS1234314" target="PULMONARY FIBROSIS">
      <data key="d4">5.0</data>
      <data key="d5">No significant differences were observed in the frequency of rs1234314 in patients with and without pulmonary fibrosis</data>
      <data key="d6">31513af83d109f0e11eca33fa5fb3204</data>
    </edge>
    <edge source="RS1234314" target="PULMONARY HYPERTENSION">
      <data key="d4">5.0</data>
      <data key="d5">No significant differences were observed in the frequency of rs1234314 in patients with and without pulmonary hypertension</data>
      <data key="d6">31513af83d109f0e11eca33fa5fb3204</data>
    </edge>
    <edge source="RS1234314" target="GENDER">
      <data key="d4">6.0</data>
      <data key="d5">The association of rs1234314 with systemic sclerosis was no longer observed after controlling for gender</data>
      <data key="d6">31513af83d109f0e11eca33fa5fb3204</data>
    </edge>
    <edge source="RS1234314" target="LIMITED SYSTEMIC SCLEROSIS">
      <data key="d4">14.0</data>
      <data key="d5">SNP rs1234314 is associated with limited systemic sclerosis</data>
      <data key="d6">e2d4a3467d27e6de3b2eea8b20f310e8</data>
    </edge>
    <edge source="RS1234314" target="DIFFUSE SYSTEMIC SCLEROSIS">
      <data key="d4">14.0</data>
      <data key="d5">SNP rs1234314 is associated with diffuse systemic sclerosis</data>
      <data key="d6">e2d4a3467d27e6de3b2eea8b20f310e8</data>
    </edge>
    <edge source="RS2205960" target="LSSC">
      <data key="d4">7.0</data>
      <data key="d5">SNP rs2205960 is more common in limited systemic sclerosis compared to controls</data>
      <data key="d6">31513af83d109f0e11eca33fa5fb3204</data>
    </edge>
    <edge source="RS2205960" target="DSSC">
      <data key="d4">7.0</data>
      <data key="d5">SNP rs2205960 is more common in diffuse systemic sclerosis compared to controls</data>
      <data key="d6">31513af83d109f0e11eca33fa5fb3204</data>
    </edge>
    <edge source="RS2205960" target="ATA">
      <data key="d4">14.0</data>
      <data key="d5">SNP rs2205960 is more frequent in ATA-positive systemic sclerosis compared to controls</data>
      <data key="d6">31513af83d109f0e11eca33fa5fb3204</data>
    </edge>
    <edge source="RS2205960" target="PULMONARY FIBROSIS">
      <data key="d4">5.0</data>
      <data key="d5">No significant differences were observed in the frequency of rs2205960 in patients with and without pulmonary fibrosis</data>
      <data key="d6">31513af83d109f0e11eca33fa5fb3204</data>
    </edge>
    <edge source="RS2205960" target="PULMONARY HYPERTENSION">
      <data key="d4">5.0</data>
      <data key="d5">No significant differences were observed in the frequency of rs2205960 in patients with and without pulmonary hypertension</data>
      <data key="d6">31513af83d109f0e11eca33fa5fb3204</data>
    </edge>
    <edge source="RS2205960" target="GENDER">
      <data key="d4">7.0</data>
      <data key="d5">The association of rs2205960 with systemic sclerosis was confirmed after controlling for gender</data>
      <data key="d6">31513af83d109f0e11eca33fa5fb3204</data>
    </edge>
    <edge source="RS2205960" target="LIMITED SYSTEMIC SCLEROSIS">
      <data key="d4">14.0</data>
      <data key="d5">SNP rs2205960 is associated with limited systemic sclerosis</data>
      <data key="d6">e2d4a3467d27e6de3b2eea8b20f310e8</data>
    </edge>
    <edge source="RS2205960" target="DIFFUSE SYSTEMIC SCLEROSIS">
      <data key="d4">14.0</data>
      <data key="d5">SNP rs2205960 is associated with diffuse systemic sclerosis</data>
      <data key="d6">e2d4a3467d27e6de3b2eea8b20f310e8</data>
    </edge>
    <edge source="RS2205960" target="AIF1">
      <data key="d4">8.0</data>
      <data key="d5">AIF1 and SNP rs2205960 are associated with systemic sclerosis</data>
      <data key="d6">f286191a8009d9c0ef61d3de0938f0e6</data>
    </edge>
    <edge source="RS844648" target="DSSC">
      <data key="d4">7.0</data>
      <data key="d5">SNP rs844648 is more common in diffuse systemic sclerosis compared to controls</data>
      <data key="d6">31513af83d109f0e11eca33fa5fb3204</data>
    </edge>
    <edge source="RS844648" target="ARA">
      <data key="d4">8.0</data>
      <data key="d5">SNP rs844648 is associated with ARA-positive systemic sclerosis compared to controls</data>
      <data key="d6">31513af83d109f0e11eca33fa5fb3204</data>
    </edge>
    <edge source="RS844648" target="PULMONARY FIBROSIS">
      <data key="d4">5.0</data>
      <data key="d5">No significant differences were observed in the frequency of rs844648 in patients with and without pulmonary fibrosis</data>
      <data key="d6">31513af83d109f0e11eca33fa5fb3204</data>
    </edge>
    <edge source="RS844648" target="PULMONARY HYPERTENSION">
      <data key="d4">5.0</data>
      <data key="d5">No significant differences were observed in the frequency of rs844648 in patients with and without pulmonary hypertension</data>
      <data key="d6">31513af83d109f0e11eca33fa5fb3204</data>
    </edge>
    <edge source="RS844648" target="GENDER">
      <data key="d4">7.0</data>
      <data key="d5">The association of rs844648 with systemic sclerosis was confirmed after controlling for gender</data>
      <data key="d6">31513af83d109f0e11eca33fa5fb3204</data>
    </edge>
    <edge source="RS844648" target="LIMITED SYSTEMIC SCLEROSIS">
      <data key="d4">14.0</data>
      <data key="d5">SNP rs844648 is associated with limited systemic sclerosis</data>
      <data key="d6">e2d4a3467d27e6de3b2eea8b20f310e8</data>
    </edge>
    <edge source="RS844648" target="DIFFUSE SYSTEMIC SCLEROSIS">
      <data key="d4">14.0</data>
      <data key="d5">SNP rs844648 is associated with diffuse systemic sclerosis</data>
      <data key="d6">e2d4a3467d27e6de3b2eea8b20f310e8</data>
    </edge>
    <edge source="RS844644" target="DSSC">
      <data key="d4">6.0</data>
      <data key="d5">SNP rs844644 is less common in diffuse systemic sclerosis compared to controls</data>
      <data key="d6">31513af83d109f0e11eca33fa5fb3204</data>
    </edge>
    <edge source="RS844644" target="PULMONARY FIBROSIS">
      <data key="d4">5.0</data>
      <data key="d5">No significant differences were observed in the frequency of rs844644 in patients with and without pulmonary fibrosis</data>
      <data key="d6">31513af83d109f0e11eca33fa5fb3204</data>
    </edge>
    <edge source="RS844644" target="PULMONARY HYPERTENSION">
      <data key="d4">5.0</data>
      <data key="d5">No significant differences were observed in the frequency of rs844644 in patients with and without pulmonary hypertension</data>
      <data key="d6">31513af83d109f0e11eca33fa5fb3204</data>
    </edge>
    <edge source="RS844644" target="GENDER">
      <data key="d4">1.0</data>
      <data key="d5">The minor allele at rs844644 was protective in all groups except for the patients who were ARA positive</data>
      <data key="d6">31513af83d109f0e11eca33fa5fb3204</data>
    </edge>
    <edge source="RS844644" target="LIMITED SYSTEMIC SCLEROSIS">
      <data key="d4">14.0</data>
      <data key="d5">SNP rs844644 is associated with limited systemic sclerosis</data>
      <data key="d6">e2d4a3467d27e6de3b2eea8b20f310e8</data>
    </edge>
    <edge source="RS844644" target="DIFFUSE SYSTEMIC SCLEROSIS">
      <data key="d4">14.0</data>
      <data key="d5">SNP rs844644 is associated with diffuse systemic sclerosis</data>
      <data key="d6">e2d4a3467d27e6de3b2eea8b20f310e8</data>
    </edge>
    <edge source="PTPN22" target="TIDM">
      <data key="d4">7.0</data>
      <data key="d5">PTPN22 is associated with the development of type I diabetes mellitus</data>
      <data key="d6">87174642d9d24116b8cc01fca23746f2</data>
    </edge>
    <edge source="PTPN22" target="RA">
      <data key="d4">7.0</data>
      <data key="d5">PTPN22 is associated with the development of rheumatoid arthritis</data>
      <data key="d6">87174642d9d24116b8cc01fca23746f2</data>
    </edge>
    <edge source="PTPN22" target="RHEUMATOID ARTHRITIS">
      <data key="d4">8.0</data>
      <data key="d5">PTPN22 is associated with rheumatoid arthritis</data>
      <data key="d6">5639a5e5649646c1e4c8deb1e1f0a1b1</data>
    </edge>
    <edge source="PTPN22" target="TYPE I DIABETES">
      <data key="d4">8.0</data>
      <data key="d5">PTPN22 is associated with type I diabetes</data>
      <data key="d6">5639a5e5649646c1e4c8deb1e1f0a1b1</data>
    </edge>
    <edge source="RA" target="STAT4">
      <data key="d4">7.0</data>
      <data key="d5">STAT4 is a susceptibility gene for rheumatoid arthritis</data>
      <data key="d6">87174642d9d24116b8cc01fca23746f2</data>
    </edge>
    <edge source="CREST" target="RAYNAUD&#8217;S PHENOMENON">
      <data key="d4">8.0</data>
      <data key="d5">Raynaud&#8217;s phenomenon is one of the features of CREST</data>
      <data key="d6">c89a7a896cf934207d874042e48857da</data>
    </edge>
    <edge source="CREST" target="ESOPHAGEAL DYSFUNCTION">
      <data key="d4">8.0</data>
      <data key="d5">Esophageal dysfunction is one of the features of CREST</data>
      <data key="d6">c89a7a896cf934207d874042e48857da</data>
    </edge>
    <edge source="CREST" target="SCLERODACTYLY">
      <data key="d4">8.0</data>
      <data key="d5">Sclerodactyly is one of the features of CREST</data>
      <data key="d6">c89a7a896cf934207d874042e48857da</data>
    </edge>
    <edge source="CREST" target="TELANGIECTASIAS">
      <data key="d4">8.0</data>
      <data key="d5">Telangiectasias is one of the features of CREST</data>
      <data key="d6">c89a7a896cf934207d874042e48857da</data>
    </edge>
    <edge source="CREST" target="CALCINOSIS">
      <data key="d4">8.0</data>
      <data key="d5">Calcinosis is one of the features of CREST</data>
      <data key="d6">c89a7a896cf934207d874042e48857da</data>
    </edge>
    <edge source="HEP-2 CELLS" target="ANTINUCLEAR ANTIBODIES">
      <data key="d4">8.0</data>
      <data key="d5">HEp-2 cells are used as an antigen substrate to test for antinuclear antibodies</data>
      <data key="d6">c89a7a896cf934207d874042e48857da</data>
    </edge>
    <edge source="HEP-2 CELLS" target="ANTI-CENTROMERE ANTIBODIES">
      <data key="d4">8.0</data>
      <data key="d5">HEp-2 cells are used to identify anti-centromere antibodies by their distinctive pattern</data>
      <data key="d6">c89a7a896cf934207d874042e48857da</data>
    </edge>
    <edge source="TOPOISOMERASE I" target="ANTI-RNA POLYMERASE III ANTIBODIES">
      <data key="d4">7.0</data>
      <data key="d5">Topoisomerase I and anti-RNA polymerase III antibodies are autoantibodies tested in patients</data>
      <data key="d6">c89a7a896cf934207d874042e48857da</data>
    </edge>
    <edge source="TOPOISOMERASE I" target="ANTI-TOPOISOMERASE I ANTIBODIES">
      <data key="d4">8.0</data>
      <data key="d5">Anti-topoisomerase I antibodies target the enzyme topoisomerase I</data>
      <data key="d6">c89a7a896cf934207d874042e48857da</data>
    </edge>
    <edge source="PUREGENE GENOMIC DNA ISOLATION KIT" target="PERIPHERAL BLOOD">
      <data key="d4">7.0</data>
      <data key="d5">Peripheral blood is used with the PureGene genomic DNA isolation kit for DNA extraction</data>
      <data key="d6">c89a7a896cf934207d874042e48857da</data>
    </edge>
    <edge source="HAPLOTYPE" target="OMNIBUS TEST">
      <data key="d4">1.0</data>
      <data key="d5">Omnibus test is used to detect differences in haplotype frequency profiles</data>
      <data key="d6">c89a7a896cf934207d874042e48857da</data>
    </edge>
    <edge source="SYSTEMIC SCLEROSIS" target="SCLERODERMA">
      <data key="d4">10.0</data>
      <data key="d5">Systemic sclerosis and scleroderma are the same disease</data>
      <data key="d6">f286191a8009d9c0ef61d3de0938f0e6</data>
    </edge>
    <edge source="SYSTEMIC SCLEROSIS" target="ANGIOGENESIS">
      <data key="d4">7.0</data>
      <data key="d5">Abnormal angiogenesis is observed in patients with systemic sclerosis</data>
      <data key="d6">f286191a8009d9c0ef61d3de0938f0e6</data>
    </edge>
    <edge source="SYSTEMIC SCLEROSIS" target="FAMILIAL SYSTEMIC SCLEROSIS">
      <data key="d4">8.0</data>
      <data key="d5">Familial systemic sclerosis indicates a genetic component in systemic sclerosis</data>
      <data key="d6">f286191a8009d9c0ef61d3de0938f0e6</data>
    </edge>
    <edge source="SYSTEMIC SCLEROSIS" target="ANTI-NUCLEAR ANTIBODY">
      <data key="d4">8.0</data>
      <data key="d5">Anti-nuclear antibodies are often found in systemic sclerosis patients</data>
      <data key="d6">f286191a8009d9c0ef61d3de0938f0e6</data>
    </edge>
    <edge source="SYSTEMIC SCLEROSIS" target="PROGRESSIVE SYSTEMIC SCLEROSIS">
      <data key="d4">1.0</data>
      <data key="d5">Progressive systemic sclerosis is a severe form of systemic sclerosis</data>
      <data key="d6">f286191a8009d9c0ef61d3de0938f0e6</data>
    </edge>
    <edge source="RS944648" target="AIF1">
      <data key="d4">8.0</data>
      <data key="d5">AIF1 and SNP rs944648 are associated with systemic sclerosis</data>
      <data key="d6">f286191a8009d9c0ef61d3de0938f0e6</data>
    </edge>
    <edge source="CD4+ T CELL" target="OX40">
      <data key="d4">16.0</data>
      <data key="d5">OX40 is expressed on CD4+ T cells</data>
      <data key="d6">ab372f2a5df06a33e153fa648bb2b950</data>
    </edge>
    <edge source="CD8+ T CELL" target="OX40">
      <data key="d4">16.0</data>
      <data key="d5">OX40 is expressed on CD8+ T cells</data>
      <data key="d6">ab372f2a5df06a33e153fa648bb2b950</data>
    </edge>
    <edge source="DIABETES" target="OX40">
      <data key="d4">7.0</data>
      <data key="d5">OX40/OX40L interaction is targeted to prevent diabetes in NOD mice</data>
      <data key="d6">f286191a8009d9c0ef61d3de0938f0e6</data>
    </edge>
    <edge source="EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS" target="OX40">
      <data key="d4">7.0</data>
      <data key="d5">OX40L is critical in the development of experimental autoimmune encephalomyelitis</data>
      <data key="d6">f286191a8009d9c0ef61d3de0938f0e6</data>
    </edge>
    <edge source="DENDRITIC CELL" target="OX40">
      <data key="d4">7.0</data>
      <data key="d5">OX40 unleashes dendritic cells by inactivating T-reg cells, allowing adaptive immune response</data>
      <data key="d6">f286191a8009d9c0ef61d3de0938f0e6</data>
    </edge>
    <edge source="OX40" target="T-REG CELL">
      <data key="d4">7.0</data>
      <data key="d5">OX40 mediates inactivation of T-reg cell function</data>
      <data key="d6">f286191a8009d9c0ef61d3de0938f0e6</data>
    </edge>
    <edge source="OX40" target="OX40/OX40L INTERACTION">
      <data key="d4">9.0</data>
      <data key="d5">OX40 is part of the OX40/OX40L interaction</data>
      <data key="d6">f286191a8009d9c0ef61d3de0938f0e6</data>
    </edge>
    <edge source="OX40" target="SERUM SOLUBLE OX40">
      <data key="d4">8.0</data>
      <data key="d5">Increased serum soluble OX40 is found in systemic sclerosis patients</data>
      <data key="d6">f286191a8009d9c0ef61d3de0938f0e6</data>
    </edge>
    <edge source="OX40" target="ATOPIC DERMATITIS">
      <data key="d4">9.0</data>
      <data key="d5">OX40 is crucial for the generation of Th2 memory cells, which are central to the pathogenesis of atopic dermatitis</data>
      <data key="d6">a98a120ac25d0f8a533fcdcd479913b1</data>
    </edge>
    <edge source="OX40" target="AD">
      <data key="d4">40.0</data>
      <data key="d5">OX40 is highly expressed by skin-homing T cells and monocytes in atopic dermatitis (AD). OX40 levels are measured in patients with atopic dermatitis, and OX40-expressing cells are localized to the skin of these patients. Additionally, OX40-positive cells are present in the skin of patients with atopic dermatitis, indicating a significant role of OX40 in the pathophysiology of this condition.</data>
      <data key="d6">05fe283d6fa879523f3ab153815ac64b,2712037f85fc28b3e86b92a719cb7a6c,7a1160d4230f62889d47499ed90adcdd,919f7083e77a7d3378489efeffa0faed</data>
    </edge>
    <edge source="OX40" target="SCORAD">
      <data key="d4">7.0</data>
      <data key="d5">OX40 expression in T cells inversely correlates with SCORAD in AD</data>
      <data key="d6">919f7083e77a7d3378489efeffa0faed</data>
    </edge>
    <edge source="OX40" target="T CELLS">
      <data key="d4">8.0</data>
      <data key="d5">OX40 is mainly expressed by skin-homing memory-prone CLA+ T cells in AD</data>
      <data key="d6">919f7083e77a7d3378489efeffa0faed</data>
    </edge>
    <edge source="OX40" target="PBMCS">
      <data key="d4">6.0</data>
      <data key="d5">OX40 expression is studied in PBMCs from AD patients</data>
      <data key="d6">919f7083e77a7d3378489efeffa0faed</data>
    </edge>
    <edge source="OX40" target="HC">
      <data key="d4">6.0</data>
      <data key="d5">OX40 expression is compared between AD patients and healthy controls</data>
      <data key="d6">919f7083e77a7d3378489efeffa0faed</data>
    </edge>
    <edge source="OX40" target="CD4+CD45RO+CLA+ T CELLS">
      <data key="d4">16.0</data>
      <data key="d5">OX40 and CD4+CD45RO+CLA+ T cells are closely associated in the context of atopic dermatitis (AD). CD4+CD45RO+CLA+ T cells, which are a subset of T cells, express high levels of OX40 in individuals with atopic dermatitis. This elevated expression of OX40 on CD4+CD45RO+CLA+ T cells is a notable feature in AD patients, indicating a potential role for OX40 in the pathophysiology of this autoimmune condition.</data>
      <data key="d6">7a1160d4230f62889d47499ed90adcdd,919f7083e77a7d3378489efeffa0faed</data>
    </edge>
    <edge source="OX40" target="CD4+CD45RO+CLA- T CELLS">
      <data key="d4">8.0</data>
      <data key="d5">OX40 is highly expressed in CD4+CD45RO+CLA- T cells in AD patients</data>
      <data key="d6">919f7083e77a7d3378489efeffa0faed</data>
    </edge>
    <edge source="OX40" target="CD8+CD45RO+CLA+ T CELLS">
      <data key="d4">7.0</data>
      <data key="d5">OX40 is expressed in CD8+CD45RO+CLA+ T cells in AD patients</data>
      <data key="d6">919f7083e77a7d3378489efeffa0faed</data>
    </edge>
    <edge source="OX40" target="CD8+CD45RO+CLA- T CELLS">
      <data key="d4">7.0</data>
      <data key="d5">OX40 is expressed in CD8+CD45RO+CLA- T cells in AD patients</data>
      <data key="d6">919f7083e77a7d3378489efeffa0faed</data>
    </edge>
    <edge source="OX40" target="MFI">
      <data key="d4">15.0</data>
      <data key="d5">OX40 is a molecule whose expression levels are measured using median fluorescence intensity (MFI) in patients with atopic dermatitis (AD). Studies have shown that the median fluorescence intensity of OX40 is significantly higher among patients with atopic dermatitis, indicating a potential role of OX40 in the pathophysiology of this autoimmune condition.</data>
      <data key="d6">7a1160d4230f62889d47499ed90adcdd,919f7083e77a7d3378489efeffa0faed</data>
    </edge>
    <edge source="OX40" target="SKIN">
      <data key="d4">8.0</data>
      <data key="d5">OX40 and OX40L are co-localized in the skin of AD patients</data>
      <data key="d6">919f7083e77a7d3378489efeffa0faed</data>
    </edge>
    <edge source="OX40" target="MAST CELLS">
      <data key="d4">1.0</data>
      <data key="d5">OX40 is present on the surface of OX40L-expressing mast cells in AD</data>
      <data key="d6">919f7083e77a7d3378489efeffa0faed</data>
    </edge>
    <edge source="OX40" target="DAPI">
      <data key="d4">6.0</data>
      <data key="d5">Nuclear staining was carried out by DAPI to identify OX40-positive cells</data>
      <data key="d6">7a1160d4230f62889d47499ed90adcdd</data>
    </edge>
    <edge source="OX40" target="TNF-SUPER FAMILY">
      <data key="d4">7.0</data>
      <data key="d5">OX40 is a member of the TNF-super family</data>
      <data key="d6">7a1160d4230f62889d47499ed90adcdd</data>
    </edge>
    <edge source="OX40" target="SKIN-HOMING CD4+ T CELLS">
      <data key="d4">8.0</data>
      <data key="d5">Skin-homing CD4+ T cells from patients with atopic dermatitis show increased expression of OX40</data>
      <data key="d6">7a1160d4230f62889d47499ed90adcdd</data>
    </edge>
    <edge source="OX40" target="LOCAL INFLAMMATION">
      <data key="d4">8.0</data>
      <data key="d5">Increased expression of OX40 on skin-homing T cells enhances local inflammation</data>
      <data key="d6">7a1160d4230f62889d47499ed90adcdd</data>
    </edge>
    <edge source="OX40" target="INFLAMMATORY REACTION">
      <data key="d4">16.0</data>
      <data key="d5">OX40 system plays a pivotal role in the inflammatory reaction in the skin</data>
      <data key="d6">2712037f85fc28b3e86b92a719cb7a6c</data>
    </edge>
    <edge source="OX40" target="ATOPIC CO-MORBIDITIES">
      <data key="d4">14.0</data>
      <data key="d5">OX40 system is associated with atopic co-morbidities in atopic dermatitis</data>
      <data key="d6">2712037f85fc28b3e86b92a719cb7a6c</data>
    </edge>
    <edge source="OX40" target="BCL-XL">
      <data key="d4">8.0</data>
      <data key="d5">OX40 promotes the expression of Bcl-xL</data>
      <data key="d6">2712037f85fc28b3e86b92a719cb7a6c</data>
    </edge>
    <edge source="OX40" target="BCL-2">
      <data key="d4">8.0</data>
      <data key="d5">OX40 promotes the expression of Bcl-2</data>
      <data key="d6">2712037f85fc28b3e86b92a719cb7a6c</data>
    </edge>
    <edge source="OX40" target="CD4 T CELLS">
      <data key="d4">8.0</data>
      <data key="d5">OX40 is essential for the long-term survival of CD4 T cells</data>
      <data key="d6">2712037f85fc28b3e86b92a719cb7a6c</data>
    </edge>
    <edge source="OX40" target="MEMORY CD4 T CELLS">
      <data key="d4">8.0</data>
      <data key="d5">OX40 determines the development of memory CD4 T cells</data>
      <data key="d6">2712037f85fc28b3e86b92a719cb7a6c</data>
    </edge>
    <edge source="CTLA4" target="RHEUMATOID ARTHRITIS">
      <data key="d4">7.0</data>
      <data key="d5">CTLA4 is associated with rheumatoid arthritis</data>
      <data key="d6">5639a5e5649646c1e4c8deb1e1f0a1b1</data>
    </edge>
    <edge source="PADI4" target="RHEUMATOID ARTHRITIS">
      <data key="d4">7.0</data>
      <data key="d5">PADI4 is associated with rheumatoid arthritis</data>
      <data key="d6">5639a5e5649646c1e4c8deb1e1f0a1b1</data>
    </edge>
    <edge source="RHEUMATOID ARTHRITIS" target="IGG">
      <data key="d4">6.0</data>
      <data key="d5">Anti-animal IgG antibodies in plasma from arthritis patients can cause false results in assays</data>
      <data key="d6">2712037f85fc28b3e86b92a719cb7a6c</data>
    </edge>
    <edge source="CREST SYNDROME" target="ANTICENTROMERE ANTIBODIES">
      <data key="d4">9.0</data>
      <data key="d5">CREST syndrome is associated with anticentromere antibodies</data>
      <data key="d6">f286191a8009d9c0ef61d3de0938f0e6</data>
    </edge>
    <edge source="TNF" target="MAST CELLS">
      <data key="d4">7.0</data>
      <data key="d5">Mast cells secrete TNF, which enhances T cell activation</data>
      <data key="d6">2712037f85fc28b3e86b92a719cb7a6c</data>
    </edge>
    <edge source="TNF" target="T CELLS">
      <data key="d4">7.0</data>
      <data key="d5">TNF is involved in the activation and survival of T cells</data>
      <data key="d6">2712037f85fc28b3e86b92a719cb7a6c</data>
    </edge>
    <edge source="HLA-DQB1" target="ANTI-TOPOISOMERASE I AUTOANTIBODY">
      <data key="d4">8.0</data>
      <data key="d5">HLA-DQB1 is associated with anti-topoisomerase I autoantibody response in scleroderma</data>
      <data key="d6">f286191a8009d9c0ef61d3de0938f0e6</data>
    </edge>
    <edge source="BLADDER CANCER" target="DNA-REPAIR GENES">
      <data key="d4">8.0</data>
      <data key="d5">DNA-repair genes are linked to bladder cancer predisposition</data>
      <data key="d6">f286191a8009d9c0ef61d3de0938f0e6</data>
    </edge>
    <edge source="BLADDER CANCER" target="CELL-CYCLE-CONTROL GENES">
      <data key="d4">1.0</data>
      <data key="d5">Cell-cycle-control genes are associated with bladder cancer predisposition</data>
      <data key="d6">f286191a8009d9c0ef61d3de0938f0e6</data>
    </edge>
    <edge source="OX40/OX40L INTERACTION" target="AUTOIMMUNE-LIKE DISEASES">
      <data key="d4">7.0</data>
      <data key="d5">Constitutive OX40/OX40L interaction induces autoimmune-like diseases</data>
      <data key="d6">f286191a8009d9c0ef61d3de0938f0e6</data>
    </edge>
    <edge source="ATOPIC DERMATITIS" target="ASTHMA">
      <data key="d4">7.0</data>
      <data key="d5">Asthma is often associated with atopic dermatitis</data>
      <data key="d6">a98a120ac25d0f8a533fcdcd479913b1</data>
    </edge>
    <edge source="ATOPIC DERMATITIS" target="ALLERGIC RHINITIS">
      <data key="d4">7.0</data>
      <data key="d5">Allergic rhinitis is often associated with atopic dermatitis</data>
      <data key="d6">a98a120ac25d0f8a533fcdcd479913b1</data>
    </edge>
    <edge source="ATOPIC DERMATITIS" target="TH2 CELLS">
      <data key="d4">8.0</data>
      <data key="d5">Th2 cells dominate the inflammatory response in atopic dermatitis</data>
      <data key="d6">a98a120ac25d0f8a533fcdcd479913b1</data>
    </edge>
    <edge source="ATOPIC DERMATITIS" target="SOX40">
      <data key="d4">7.0</data>
      <data key="d5">Serum levels of sOX40 are decreased in patients with atopic dermatitis</data>
      <data key="d6">a98a120ac25d0f8a533fcdcd479913b1</data>
    </edge>
    <edge source="ATOPIC DERMATITIS" target="CD4+ T CELLS">
      <data key="d4">8.0</data>
      <data key="d5">Expression of OX40 by activated skin-homing CD4+ T cells is increased in atopic dermatitis</data>
      <data key="d6">a98a120ac25d0f8a533fcdcd479913b1</data>
    </edge>
    <edge source="ATOPIC DERMATITIS" target="IGE">
      <data key="d4">7.0</data>
      <data key="d5">Elevated levels of IgE are found in up to 80% of patients with atopic dermatitis</data>
      <data key="d6">a98a120ac25d0f8a533fcdcd479913b1</data>
    </edge>
    <edge source="ATOPIC DERMATITIS" target="MAST CELLS">
      <data key="d4">8.0</data>
      <data key="d5">Mast cells are involved in the production of Th2 driving cytokines in atopic dermatitis</data>
      <data key="d6">a98a120ac25d0f8a533fcdcd479913b1</data>
    </edge>
    <edge source="ATOPIC DERMATITIS" target="IL-4">
      <data key="d4">8.0</data>
      <data key="d5">IL-4 is a central mediator of atopic dermatitis pathogenesis</data>
      <data key="d6">a98a120ac25d0f8a533fcdcd479913b1</data>
    </edge>
    <edge source="ATOPIC DERMATITIS" target="IL-25">
      <data key="d4">8.0</data>
      <data key="d5">IL-25 is a central mediator of atopic dermatitis pathogenesis</data>
      <data key="d6">a98a120ac25d0f8a533fcdcd479913b1</data>
    </edge>
    <edge source="ATOPIC DERMATITIS" target="SCORAD">
      <data key="d4">7.0</data>
      <data key="d5">SCORAD is used to assess the severity of atopic dermatitis</data>
      <data key="d6">a98a120ac25d0f8a533fcdcd479913b1</data>
    </edge>
    <edge source="ATOPIC DERMATITIS" target="PBMCS">
      <data key="d4">1.0</data>
      <data key="d5">PBMCs are collected from patients with atopic dermatitis for immune response studies</data>
      <data key="d6">a98a120ac25d0f8a533fcdcd479913b1</data>
    </edge>
    <edge source="ATOPIC DERMATITIS" target="ECZEMA">
      <data key="d4">8.0</data>
      <data key="d5">Eczema is a common symptom of atopic dermatitis</data>
      <data key="d6">a98a120ac25d0f8a533fcdcd479913b1</data>
    </edge>
    <edge source="ATOPIC DERMATITIS" target="PRURITUS">
      <data key="d4">8.0</data>
      <data key="d5">Pruritus is a common symptom of atopic dermatitis</data>
      <data key="d6">a98a120ac25d0f8a533fcdcd479913b1</data>
    </edge>
    <edge source="ATOPIC DERMATITIS" target="DRY SKIN">
      <data key="d4">8.0</data>
      <data key="d5">Dry skin is a common symptom of atopic dermatitis</data>
      <data key="d6">a98a120ac25d0f8a533fcdcd479913b1</data>
    </edge>
    <edge source="ATOPIC DERMATITIS" target="MEMORY T CELLS">
      <data key="d4">8.0</data>
      <data key="d5">Memory T cells are central to the chronicity of atopic dermatitis</data>
      <data key="d6">a98a120ac25d0f8a533fcdcd479913b1</data>
    </edge>
    <edge source="ATOPIC DERMATITIS" target="APC">
      <data key="d4">8.0</data>
      <data key="d5">APC express OX40L and are involved in the immune response in atopic dermatitis</data>
      <data key="d6">a98a120ac25d0f8a533fcdcd479913b1</data>
    </edge>
    <edge source="ATOPIC DERMATITIS" target="SOX40L">
      <data key="d4">7.0</data>
      <data key="d5">sOX40L has an anti-inflammatory effect in atopic dermatitis</data>
      <data key="d6">a98a120ac25d0f8a533fcdcd479913b1</data>
    </edge>
    <edge source="ATOPIC DERMATITIS" target="HANIFIN &amp; RAJKA CRITERIA">
      <data key="d4">7.0</data>
      <data key="d5">The Hanifin &amp; Rajka criteria are used for diagnosing atopic dermatitis</data>
      <data key="d6">a98a120ac25d0f8a533fcdcd479913b1</data>
    </edge>
    <edge source="ATOPIC DERMATITIS" target="PLASMA">
      <data key="d4">1.0</data>
      <data key="d5">Plasma is collected from patients with atopic dermatitis for various analyses</data>
      <data key="d6">a98a120ac25d0f8a533fcdcd479913b1</data>
    </edge>
    <edge source="ASTHMA" target="AD">
      <data key="d4">14.0</data>
      <data key="d5">Asthma and atopic dermatitis (AD) are often comorbid conditions, meaning they frequently occur together in the same patients. Many individuals with atopic dermatitis also suffer from asthma, highlighting a significant overlap between these two conditions.</data>
      <data key="d6">05fe283d6fa879523f3ab153815ac64b,7a1160d4230f62889d47499ed90adcdd</data>
    </edge>
    <edge source="ASTHMA" target="SOX40">
      <data key="d4">7.0</data>
      <data key="d5">Higher sOX40 serum levels are observed in AD patients with asthma</data>
      <data key="d6">919f7083e77a7d3378489efeffa0faed</data>
    </edge>
    <edge source="ASTHMA" target="SERUM OX40 LIGAND">
      <data key="d4">1.0</data>
      <data key="d5">Serum OX40 ligand levels can be a potential biomarker of severity and persistence in asthmatic children</data>
      <data key="d6">2712037f85fc28b3e86b92a719cb7a6c</data>
    </edge>
    <edge source="ALLERGIC RHINITIS" target="AD">
      <data key="d4">6.0</data>
      <data key="d5">Some patients with atopic dermatitis also have allergic rhinitis</data>
      <data key="d6">7a1160d4230f62889d47499ed90adcdd</data>
    </edge>
    <edge source="SOX40" target="AD">
      <data key="d4">37.0</data>
      <data key="d5">SOX40 and AD (Atopic Dermatitis) are closely associated in medical research. Serum levels of soluble OX40 (sOX40) are measured in patients with atopic dermatitis. Studies indicate that serum levels of sOX40 are associated with atopic dermatitis, and it has been observed that these levels are decreased in patients suffering from this condition. This suggests that sOX40 could potentially serve as a biomarker for atopic dermatitis, providing insights into the disease's pathology and aiding in its diagnosis and management.</data>
      <data key="d6">05fe283d6fa879523f3ab153815ac64b,2f4bf4583547aaf1c5cc6eaea0b058eb,7a1160d4230f62889d47499ed90adcdd,919f7083e77a7d3378489efeffa0faed</data>
    </edge>
    <edge source="SOX40" target="SCORAD">
      <data key="d4">13.0</data>
      <data key="d5">SOX40 and SCORAD are closely related in the context of atopic dermatitis (AD). Research indicates a correlation between sOX40 levels and the SCORAD index, which is a clinical tool used to assess the severity of atopic dermatitis. Specifically, sOX40 levels have been found to correlate with the SCORAD index in children with AD, suggesting that sOX40 could potentially serve as a biomarker for disease severity in this population.</data>
      <data key="d6">05fe283d6fa879523f3ab153815ac64b,919f7083e77a7d3378489efeffa0faed</data>
    </edge>
    <edge source="SOX40" target="IGE">
      <data key="d4">1.0</data>
      <data key="d5">Correlation between sOX40 levels and IgE in atopic dermatitis</data>
      <data key="d6">05fe283d6fa879523f3ab153815ac64b</data>
    </edge>
    <edge source="SOX40" target="HC">
      <data key="d4">7.0</data>
      <data key="d5">sOX40 levels are compared between patients with atopic dermatitis and healthy controls</data>
      <data key="d6">05fe283d6fa879523f3ab153815ac64b</data>
    </edge>
    <edge source="SOX40" target="SPEARMAN&#8217;S RHO">
      <data key="d4">6.0</data>
      <data key="d5">Spearman&#8217;s rho is used to assess the correlation between sOX40 levels and clinical parameters in atopic dermatitis</data>
      <data key="d6">05fe283d6fa879523f3ab153815ac64b</data>
    </edge>
    <edge source="SOX40" target="CHILDREN">
      <data key="d4">7.0</data>
      <data key="d5">Serum levels of sOX40 are associated with disease activity in children with AD</data>
      <data key="d6">919f7083e77a7d3378489efeffa0faed</data>
    </edge>
    <edge source="SOX40" target="ADULTS">
      <data key="d4">7.0</data>
      <data key="d5">Serum levels of sOX40 are associated with disease activity in adults with AD</data>
      <data key="d6">919f7083e77a7d3378489efeffa0faed</data>
    </edge>
    <edge source="SOX40" target="ELISA">
      <data key="d4">7.0</data>
      <data key="d5">Serum levels of sOX40 were measured using ELISA</data>
      <data key="d6">7a1160d4230f62889d47499ed90adcdd</data>
    </edge>
    <edge source="SOX40" target="TNF-SUPER FAMILY">
      <data key="d4">7.0</data>
      <data key="d5">sOX40 can bind to its ligand expressed by different cell types, as with all members of the TNF-super family</data>
      <data key="d6">7a1160d4230f62889d47499ed90adcdd</data>
    </edge>
    <edge source="IGE" target="AD">
      <data key="d4">8.0</data>
      <data key="d5">IgE levels are measured in patients with atopic dermatitis (AD). Serum IgE levels are specifically assessed in AD patients to help understand the immunological aspects of the disease.</data>
      <data key="d6">05fe283d6fa879523f3ab153815ac64b,919f7083e77a7d3378489efeffa0faed</data>
    </edge>
    <edge source="MAST CELLS" target="LOCAL INFLAMMATION">
      <data key="d4">1.0</data>
      <data key="d5">Mast cells interact with activated T cells through OX40-OX40L, contributing to local inflammation</data>
      <data key="d6">7a1160d4230f62889d47499ed90adcdd</data>
    </edge>
    <edge source="MAST CELLS" target="T CELLS">
      <data key="d4">14.0</data>
      <data key="d5">Mast cells interact with T cells through OX40-OX40L in the skin of patients with atopic dermatitis</data>
      <data key="d6">2712037f85fc28b3e86b92a719cb7a6c</data>
    </edge>
    <edge source="MAST CELLS" target="FC EPSILON RI">
      <data key="d4">7.0</data>
      <data key="d5">Fc epsilon RI-mediated activation of mast cells leads to the production of interleukin-25</data>
      <data key="d6">2712037f85fc28b3e86b92a719cb7a6c</data>
    </edge>
    <edge source="MAST CELLS" target="INTERLEUKIN-25">
      <data key="d4">7.0</data>
      <data key="d5">Mast cells produce interleukin-25 upon activation</data>
      <data key="d6">2712037f85fc28b3e86b92a719cb7a6c</data>
    </edge>
    <edge source="SCORAD" target="AD">
      <data key="d4">8.0</data>
      <data key="d5">SCORAD is used to assess the severity of atopic dermatitis</data>
      <data key="d6">05fe283d6fa879523f3ab153815ac64b</data>
    </edge>
    <edge source="PBMCS" target="AD">
      <data key="d4">14.0</data>
      <data key="d5">Peripheral Blood Mononuclear Cells are collected from patients with Atopic Dermatitis</data>
      <data key="d6">2f4bf4583547aaf1c5cc6eaea0b058eb</data>
    </edge>
    <edge source="PBMCS" target="CD4">
      <data key="d4">16.0</data>
      <data key="d5">CD4 is a marker used to identify T helper cells in Peripheral Blood Mononuclear Cells</data>
      <data key="d6">2f4bf4583547aaf1c5cc6eaea0b058eb</data>
    </edge>
    <edge source="PBMCS" target="CD8">
      <data key="d4">16.0</data>
      <data key="d5">CD8 is a marker used to identify cytotoxic T cells in Peripheral Blood Mononuclear Cells</data>
      <data key="d6">2f4bf4583547aaf1c5cc6eaea0b058eb</data>
    </edge>
    <edge source="PBMCS" target="CD14">
      <data key="d4">16.0</data>
      <data key="d5">CD14 is a marker used to identify macrophages in Peripheral Blood Mononuclear Cells</data>
      <data key="d6">2f4bf4583547aaf1c5cc6eaea0b058eb</data>
    </edge>
    <edge source="PBMCS" target="CD45RO">
      <data key="d4">16.0</data>
      <data key="d5">CD45RO is a marker used to identify memory T cells in Peripheral Blood Mononuclear Cells</data>
      <data key="d6">2f4bf4583547aaf1c5cc6eaea0b058eb</data>
    </edge>
    <edge source="PBMCS" target="CD56">
      <data key="d4">16.0</data>
      <data key="d5">CD56 is a marker used to identify natural killer cells in Peripheral Blood Mononuclear Cells</data>
      <data key="d6">2f4bf4583547aaf1c5cc6eaea0b058eb</data>
    </edge>
    <edge source="PBMCS" target="CLA">
      <data key="d4">16.0</data>
      <data key="d5">Cutaneous Lymphocyte Antigen is a marker used to identify skin-homing T cells in Peripheral Blood Mononuclear Cells</data>
      <data key="d6">2f4bf4583547aaf1c5cc6eaea0b058eb</data>
    </edge>
    <edge source="PBMCS" target="FICOLL-PAQUE">
      <data key="d4">16.0</data>
      <data key="d5">Ficoll-Paque is used for the isolation of Peripheral Blood Mononuclear Cells</data>
      <data key="d6">2f4bf4583547aaf1c5cc6eaea0b058eb</data>
    </edge>
    <edge source="PBMCS" target="BOVINE SERUM ALBUMIN">
      <data key="d4">14.0</data>
      <data key="d5">Bovine Serum Albumin is used in the wash buffer for Peripheral Blood Mononuclear Cells</data>
      <data key="d6">2f4bf4583547aaf1c5cc6eaea0b058eb</data>
    </edge>
    <edge source="PBMCS" target="SODIUM AZIDE">
      <data key="d4">14.0</data>
      <data key="d5">Sodium Azide is used in the wash buffer for Peripheral Blood Mononuclear Cells</data>
      <data key="d6">2f4bf4583547aaf1c5cc6eaea0b058eb</data>
    </edge>
    <edge source="SOX40L" target="AD">
      <data key="d4">28.0</data>
      <data key="d5">SOX40L and AD (Atopic Dermatitis) are closely studied in the context of autoimmune diseases. Soluble OX40 Ligand (sOX40L) levels are measured in the serum of patients with Atopic Dermatitis. However, studies indicate that serum levels of sOX40L show no significant differences between patients with Atopic Dermatitis and healthy controls. This suggests that sOX40L may not be a distinguishing biomarker for Atopic Dermatitis when compared to healthy individuals.</data>
      <data key="d6">05fe283d6fa879523f3ab153815ac64b,2f4bf4583547aaf1c5cc6eaea0b058eb,7a1160d4230f62889d47499ed90adcdd</data>
    </edge>
    <edge source="SOX40L" target="HC">
      <data key="d4">7.0</data>
      <data key="d5">sOX40L levels are compared between patients with atopic dermatitis and healthy controls</data>
      <data key="d6">05fe283d6fa879523f3ab153815ac64b</data>
    </edge>
    <edge source="SOX40L" target="ELISA">
      <data key="d4">7.0</data>
      <data key="d5">Serum levels of sOX40L were measured using ELISA</data>
      <data key="d6">7a1160d4230f62889d47499ed90adcdd</data>
    </edge>
    <edge source="AD" target="HC">
      <data key="d4">16.0</data>
      <data key="d5">Healthy controls are used as a comparison group for patients with Atopic Dermatitis</data>
      <data key="d6">2f4bf4583547aaf1c5cc6eaea0b058eb</data>
    </edge>
    <edge source="AD" target="TRYPTASE">
      <data key="d4">14.0</data>
      <data key="d5">Tryptase levels are measured in skin biopsies from patients with Atopic Dermatitis</data>
      <data key="d6">2f4bf4583547aaf1c5cc6eaea0b058eb</data>
    </edge>
    <edge source="AD" target="FORMALDEHYDE">
      <data key="d4">14.0</data>
      <data key="d5">Formaldehyde is used to fix skin biopsies from patients with Atopic Dermatitis</data>
      <data key="d6">2f4bf4583547aaf1c5cc6eaea0b058eb</data>
    </edge>
    <edge source="AD" target="PARAFFIN">
      <data key="d4">14.0</data>
      <data key="d5">Paraffin is used to embed skin biopsies from patients with Atopic Dermatitis</data>
      <data key="d6">2f4bf4583547aaf1c5cc6eaea0b058eb</data>
    </edge>
    <edge source="AD" target="XYLENE">
      <data key="d4">14.0</data>
      <data key="d5">Xylene is used to deparaffinize skin biopsies from patients with Atopic Dermatitis</data>
      <data key="d6">2f4bf4583547aaf1c5cc6eaea0b058eb</data>
    </edge>
    <edge source="AD" target="ETHANOL">
      <data key="d4">14.0</data>
      <data key="d5">Ethanol is used to rehydrate skin biopsies from patients with Atopic Dermatitis</data>
      <data key="d6">2f4bf4583547aaf1c5cc6eaea0b058eb</data>
    </edge>
    <edge source="AD" target="CITRATE-PHOSPHATE BUFFER">
      <data key="d4">14.0</data>
      <data key="d5">Citrate-Phosphate Buffer is used for antigen retrieval in skin biopsies from patients with Atopic Dermatitis</data>
      <data key="d6">2f4bf4583547aaf1c5cc6eaea0b058eb</data>
    </edge>
    <edge source="AD" target="DONKEY SERUM">
      <data key="d4">2.0</data>
      <data key="d5">Donkey Serum is used as a blocking agent in skin biopsies from patients with Atopic Dermatitis</data>
      <data key="d6">2f4bf4583547aaf1c5cc6eaea0b058eb</data>
    </edge>
    <edge source="AD" target="RHINITIS">
      <data key="d4">8.0</data>
      <data key="d5">Rhinitis is a comorbidity often found in patients with atopic dermatitis</data>
      <data key="d6">05fe283d6fa879523f3ab153815ac64b</data>
    </edge>
    <edge source="AD" target="PERIPHERAL BLOOD MONONUCLEAR CELLS">
      <data key="d4">7.0</data>
      <data key="d5">Peripheral blood mononuclear cells are analyzed in patients with atopic dermatitis</data>
      <data key="d6">05fe283d6fa879523f3ab153815ac64b</data>
    </edge>
    <edge source="AD" target="WILCOXON SIGNED-RANK TEST">
      <data key="d4">6.0</data>
      <data key="d5">The Wilcoxon signed-rank test is used to analyze paired data in studies of atopic dermatitis</data>
      <data key="d6">05fe283d6fa879523f3ab153815ac64b</data>
    </edge>
    <edge source="AD" target="MANN-WHITNEY RANK SUM TEST">
      <data key="d4">6.0</data>
      <data key="d5">The Mann-Whitney rank sum test is used to analyze unpaired data in studies of atopic dermatitis</data>
      <data key="d6">05fe283d6fa879523f3ab153815ac64b</data>
    </edge>
    <edge source="AD" target="PRISM 6">
      <data key="d4">6.0</data>
      <data key="d5">Prism 6 is used for statistical analysis and graphing in studies of atopic dermatitis</data>
      <data key="d6">05fe283d6fa879523f3ab153815ac64b</data>
    </edge>
    <edge source="AD" target="EASI">
      <data key="d4">1.0</data>
      <data key="d5">EASI score is used to measure the severity of atopic dermatitis</data>
      <data key="d6">7a1160d4230f62889d47499ed90adcdd</data>
    </edge>
    <edge source="AD" target="GBR 830">
      <data key="d4">9.0</data>
      <data key="d5">GBR 830 improves clinical scores in patients with atopic dermatitis</data>
      <data key="d6">2712037f85fc28b3e86b92a719cb7a6c</data>
    </edge>
    <edge source="TRYPTASE" target="EPR8476">
      <data key="d4">8.0</data>
      <data key="d5">EPR8476 is an antibody used to detect tryptase</data>
      <data key="d6">05fe283d6fa879523f3ab153815ac64b</data>
    </edge>
    <edge source="TRYPTASE" target="ALEXA 647">
      <data key="d4">7.0</data>
      <data key="d5">Alexa 647 is used to label antibodies against tryptase</data>
      <data key="d6">05fe283d6fa879523f3ab153815ac64b</data>
    </edge>
    <edge source="DAPI" target="PERIPHERAL BLOOD MONONUCLEAR CELLS">
      <data key="d4">7.0</data>
      <data key="d5">DAPI is used to stain DNA in peripheral blood mononuclear cells</data>
      <data key="d6">05fe283d6fa879523f3ab153815ac64b</data>
    </edge>
    <edge source="PERIPHERAL BLOOD MONONUCLEAR CELLS" target="MOUNTING MEDIUM">
      <data key="d4">6.0</data>
      <data key="d5">Mounting Medium is used to fix peripheral blood mononuclear cells on microscope slides</data>
      <data key="d6">05fe283d6fa879523f3ab153815ac64b</data>
    </edge>
    <edge source="EASI" target="ANTI-OX40 THERAPY">
      <data key="d4">16.0</data>
      <data key="d5">Anti-OX40 therapy affects the Eczema Area and Severity Index score in AD treatment</data>
      <data key="d6">2712037f85fc28b3e86b92a719cb7a6c</data>
    </edge>
    <edge source="SKIN-HOMING CD4+ T CELLS" target="INFLAMMATORY SITE">
      <data key="d4">7.0</data>
      <data key="d5">Skin-homing CD4+ T cells migrate to the inflammatory site in the skin</data>
      <data key="d6">7a1160d4230f62889d47499ed90adcdd</data>
    </edge>
    <edge source="BIOMARKERS" target="ANTI-OX40 THERAPY">
      <data key="d4">14.0</data>
      <data key="d5">Anti-OX40 therapy affects biomarkers in AD treatment</data>
      <data key="d6">2712037f85fc28b3e86b92a719cb7a6c</data>
    </edge>
    <edge source="SKIN THICKNESS" target="ANTI-OX40 THERAPY">
      <data key="d4">14.0</data>
      <data key="d5">Anti-OX40 therapy affects skin thickness in AD treatment</data>
      <data key="d6">2712037f85fc28b3e86b92a719cb7a6c</data>
    </edge>
    <edge source="LDL RECEPTOR-DEFICIENT MICE" target="OX40-OX40L">
      <data key="d4">7.0</data>
      <data key="d5">Interruption of the OX40-OX40 ligand pathway in LDL receptor-deficient mice causes regression of atherosclerosis</data>
      <data key="d6">2712037f85fc28b3e86b92a719cb7a6c</data>
    </edge>
  </graph>
</graphml>